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ABSTRACT 
DISTINCT TEMPORAL REQUIREMENTS FOR SONIC HEDGEHOG IN THE 
DEVELOPMENT OF THE TUBERAL HYPOTHALAMUS 
Tanya S. Corman 
Douglas J. Epstein, Ph.D. 
 
Sonic hedgehog (Shh) is a secreted morphogen that plays integral roles in the 
development of several brain and spinal cord regions. However, defining roles for Shh in 
the development of the hypothalamus has presented a challenge owing to its complex 
anatomy and neuronal heterogeneity.  Of particular interest is the tuberal hypothalamus, 
a brain region with important homeostatic function. Early deletions of Shh from non-
neuronal sources result in a severe brain malformation similar to a condition termed 
Holoprosenecehpaly in humans. In mouse models of this disorder, the hypothalamus 
fails to form. Later disruptions of Shh signaling within the hypothalamus itself implicate 
the hypothalamic source of Shh in proper development of the optic nerve and pituitary in 
addition to the hypothalamus. These phenotypes are associated with another disorder in 
patients termed Septo-optic dysplasia. We use conditional deletion models in mice to 
further define requirements for dynamic Shh activity at distinct stages of tuberal 
hypothalamic development. We find tuberal hypothalamic nuclei are dependent on early 
roles for Shh in dorsoventral patterning, neurogenesis, and restricting ventral midline 
area. We then utilize fate mapping techniques to demonstrate that Shh expressing and 
responsive progenitors contribute to distinct neuronal subtypes, accounting for some of 
the cellular heterogeneity in tuberal hypothalamic nuclei. Conditional deletion of the 
Hedgehog transducer Smoothened (Smo) at time points after dorsoventral patterning 
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has been established reveals that Shh signaling is necessary to maintain proliferation 
and progenitor identity during peak periods of hypothalamic neurogenesis. We also find 
that mosaic disruption of Smo causes a non-cell autonomous gain in Shh signaling 
activity in neighboring wild type cells, suggesting a possible mechanism for the growth of 
hypothalamic hamartomas, a benign tumor that forms at fetal stages of hypothalamic 
development. 
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CHAPTER 1: INTRODUCTION 
The Hypothalamus 
The hypothalamus is a highly conserved brain region which acts as a critical 
regulator of several homeostatic processes and animal behaviors. Neurons of the 
hypothalamus are responsible for controlling diverse functions required for survival of the 
organism and propagation of the species. Genetic and lesion experiments identified 
neural circuits mapping to distinct areas of the hypothalamus that are responsible for 
food intake, energy expenditure, fluid balance, temperature regulation, wakefulness, 
daily rhythms, as well as social behaviors associated with reproduction, aggression, 
arousal, and stress (Saper and Lowell, 2014; Zha and Xu, 2015; Hashikawa et al., 2017; 
Tan and Knight, 2018). In order to perform this range of functions, the hypothalamus is 
composed of a diverse array of neuronal cell types characterized by their expression of 
transcription factors, neuropeptides, neurotransmitters, and hormones (Caqueret et al., 
2006).  
An anatomically complex structure, the hypothalamus is located in the ventral 
forebrain where it sits above the pituitary gland and ventral to the thalamus (Fig. 1a). 
The hypothalamus is symmetrical in nature, each aspect duplicated on either side of the 
ventral midline. These two halves of the hypothalamus are separated by the third 
ventricle of the brain. Whereas other regions of the central nervous system are typically 
arranged in cell layers, the hypothalamus is organized into discrete clusters of neurons 
termed nuclei (Shimada and Nakamura, 1973; Altman and Bayer, 1986). The adult 
hypothalamus is divided into four principal regions along the rostral to caudal axis: 
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preoptic, anterior, tuberal, and mammillary with each region containing defined 
hypothalamic nuclei (Fig. 1B). 
The tuberal hypothalamus: 
Perhaps the best described region of the hypothalamus is the tuberal territory. 
Within the tuberal hypothalamus, beginning most ventrally, are the arcuate nucleus 
(ARC), ventromedial hypothalamic nucleus (VMH), and dorsomedial hypothalamic 
nucleus (DMH). The positioning of the tuberal hypothalamus offers unique exposure to 
peripheral cues carried through the bloodstream or cerebrospinal fluid through a 
specialized structure termed the median eminence (Yin and Gore, 2010). The median 
eminence sits at the base of the third ventricle in the tuberal hypothalamus and includes 
a fenestrated capillary bed, allowing for sensing of peripheral signals as well as allowing 
for parvocellular neurons to release hormones to be transported to the pituitary. 
Furthermore, the median eminence is derived from a specialized domain containing 
networks of radial glial cells termed tanycytes (Salvatierra et al., 2014; Rizzoti and 
Lovell-Badge, 2017). At the median eminence, these unique cell types are integral to the 
sensing of factors including insulin, leptin, and ghrelin to allow the hypothalamus to 
maintain homeostatic conditions (reviewed in Rodríguez et al., 2005; Robins et al., 2013; 
reviewed in Bolborea and Dale, 2013).  
The nuclei of the tuberal hypothalamus constitute the hypothalamic circuit that 
regulates feeding behavior and energy homeostasis (McClellan et al., 2006; Morton et 
al., 2006). Recent advances have been made in our understanding of the neuronal 
circuitry and function of the VMH in particular. The VMH is an elliptical shaped nucleus 
located above the ARC and below the DMH (Fig. 2) and can be subdivided into 
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ventrolateral (VMHVL), central (VMHC) and dorsomedial (VMHDM) regions, each with 
distinguishable gene expression profiles (Segal et al., 2005; McClellan et al., 2006; 
Kurrasch et al., 2007). Genetic, pharmacogenetic and optogenetic approaches have 
further delineated VMH neurons into functionally distinct categories. ERα-expressing 
neurons in the VMHVL regulate sexually dimorphic features related to energy expenditure, 
reproductive behavior and aggression (Lin et al., 2011; Lee et al., 2014; Correa et al., 
2015). Whereas, insulin receptor (IR) expressing neurons in the VMHC and Leptin 
Receptor (LEPR) neurons in the VMHDM effect body weight regulation in both males and 
females (Dhillon et al., 2006; Klöckener et al., 2011). Steroidogenic factor 1 (SF1, 
officially designated Nr5a1) neurons in the VMHDM also influence behavioral responses to 
fear and anxiety (Silva et al., 2013; Kunwar et al., 2015). 
  
 
Sonic Hedgehog 
Hedgehog genes: 
A major focus of developmental biology is how complex multicellular organisms 
are generated from a single cell. Early experiments in the field focused on identifying 
genes involved in establishing the layout or body plan of an organism. One such 
discovery was that of the Hedgehog (hh) gene, identified in a mutagenesis screen in 
Drosophila larvae for factors that disrupted body plan organization. Larvae mutant for hh 
displayed ectopic bristle-like structures called denticles, causing them to resemble a 
hedgehog (Nüsslein-Volhard and Wieschaus, 1980). In vertebrates, gene duplication 
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events have expanded the Hedgehog family such that mammals have Indian hedgehog 
(Ihh), Desert hedgehog (Dhh) and Sonic hedgehog (Shh). 
Though there are three Hedgehog genes in mammals, Shh is perhaps the best 
studied owing to its integral roles in the development of many tissues. Specifically, Shh 
acts as a secreted morphogen in numerous organizing centers of the developing embryo 
to pattern the limbs, central nervous system, inner ear, skin, as well as other tissues. 
The best studied context is within the central nervous system, where Shh is responsible 
for the patterning the neural tube along the dorsoventral axis (Echelard et al., 1993).  
Hedgehog signaling pathway: 
In the Shh expressing cell, Shh protein undergoes a series of post-translational 
modifications and cleavage events to produce N-terminal and C-terminal fragments 
(Bumcrot et al., 1995). Cholesterol molecules are then added to the N-terminal fragment 
of Shh, targeting the ligand for secretion (Kelley et al., 1996; Roessler et al., 1997). 
Upon release, Shh ligand travels to its cognate receptors on Shh-receiving cells. Cells 
competent to receive Shh signal will express several factors required for transduction of 
the signal. The ligand-binding receptor for Shh is the 12-pass transmembrane receptor 
Patched (Ptch). Further, the obligate transducer of Shh signal is the G-protein-coupled 
receptor-like seven-pass transmembrane protein Smoothened (Smo). In certain 
contexts, additional co-receptors are also required for proper Shh signaling. These 
include Cell Adhesion Associated, Oncogene Regulated (Cdon), Brother of Cdo (Boc) 
and Growth arrest specific 1 (Gas1). Downstream, the Glioma-associated transcription 
factors (Gli1, Gli2, and Gli3) act to activate or repress target gene transcription (Allen et 
al., 2007; Goodrich et al., 1997; Van den Heuvel and Ingham, 1996; Hui et al., 1994; 
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Kinzler et al., 1988; Lee et al., 1997; Marigo et al., 1996; Tenzen et al., 2006; Zhang and 
Jetten, 2001). Though the mechanisms are not fully understood, Shh requires the 
primary cilium organelle for proper signaling and many components of the Shh pathway 
undergo localization to the cilium as a result of Shh ligand-binding response, (Huangfu 
and Anderson, 2005; Huangfu et al., 2003; Liu et al., 2005). 
In the absence of ligand, Ptch1 is localized to the cilium, preventing the 
accumulation of Smo in this compartment. As a result, Ptch1 acts to repress the pathway 
(Rohatgi et al., 2007; Strutt et al., 2001; Taipale et al., 2002; Fig. 3.1A). Downstream, 
Gli2 and 3 are bound by Suppressor of fused (Sufu). This causes the transcription 
factors to remain in the cytoplasm where they are phosphorylated (Ding et al., 1999; 
Kogerman et al., 1999; Liu et al., 2005; Svärd et al., 2006). These phosphorylation 
events target Gli2/3 for proteolytic processing (Haycraft et al., 2005; Pan et al., 2006; 
Wang et al., 2000). Cleavage of the transcriptional activator Gli2 targets it for 
degradation. Meanwhile, cleavage of Gli3 releases an N-terminal repressor domain that 
translocates to the nucleus and acts to repress gene expression.  
Upon Shh ligand binding to Ptch1, the Ptch-mediated repression of Smo is 
alleviated. Thus, Smo is able to accumulate at the tip of the primary cilium (Chen and 
Struhl, 1998; Murone et al., 1999; Martín et al., 2001; Corbit et al., 2005; Rohatgi et al., 
2007). Smo accumulation at the membrane allows for downstream signaling resulting in 
the dissociation of Gli proteins from Sufu. Thus, Gli2 and Gli3 are maintained in their full-
length forms and are able to translocate to the nucleus to activate transcription of target 
genes, such as Gli1 (Lee et al., 1997; Wang et al., 2000; Haycraft et al., 2005; Pan et al., 
2006). 
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Shh in the neural tube: 
In the developing neural tube, Shh ligand is secreted first from the notochord, a 
mesendodermal structure residing below the neural tube. This induces a secondary 
source of Shh expression in the ventral-most cells of the neural tube termed the floor 
plate. Generation of a transgenic mouse expressing a Shh-GFP fusion protein allowed 
for in vivo imaging of the spread of Shh ligand from the notochord to the apical surface 
of cells in the ventral neural tube (Chamberlain, 2008). 
Shh ligand continues to be secreted in a graded fashion and induces the 
expression of transcription factors in a concentration dependent manner. In turn, these 
transcription factors pattern progenitor domains along the dorsoventral axis that will give 
rise to the neuronal populations of the mature spinal cord. Downstream of ligand binding, 
Shh signaling cascade results in the specification and formation of distinct domains of 
progenitor cells marked by differential expression of homeodomain and basic HLH 
transcription factors, activated in relation to the strength of Shh signaling to which it is 
exposed (Ericson et al., 1996; Ericson et al., 1997). These transcription factors include 
those termed Class I proteins, which are repressed by Shh and Class II proteins which 
are induced by and require a threshold of Shh accumulation. Nkx2.2, Olig2, and Nkx6.1 
characterize the three most ventral neural progenitor cell groups: p3, pMN, and p2, 
respectively.  Lower levels of Shh signaling also influence more dorsal p1 and p0 neural 
progenitor domains (Briscoe et al., 2000; Briscoe and Ericson, 2001). 
Shh in the hypothalamus: 
As in the spinal cord, Shh acts to pattern ventral cell fates in the developing 
hypothalamus. However, the temporal and spatial dynamics of Shh signaling in the 
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hypothalamus differ from those in more posterior regions of the CNS. Beginning at 8.5 
days of mouse development (E8.5), Shh is secreted from the prechordal plate, a 
mesendodermal structure that transiently underlies the anterior neural tube. This source 
of Shh induces signaling activity in the overlying hypothalamus. Shh signaling is then 
downregulated in ventral midline cells of the tuberal hypothalamus. This downregulation 
of Shh signaling is a step which distinguishes hypothalamic development from other 
regions of the central nervous system. In addition to Shh, additional factors are secreted 
by prechordal plate. Interestingly, BMP ligands derived from the prechordal plate are 
required for the rostralization of the neural tube to impart hypothalamic identity. (Dale et 
al., 1997; Ohyama et al., 2005). This Bmp signaling in the ventral midline upregulates 
Gli3-R expression, thus downregulating Shh signaling in the midline (Ohyama et al., 
2008).  
Following the extinguishing of Shh signaling in the hypothalamic midline, a 
secondary source of Shh transcription is induced in the hypothalamus itself between 
E9.0-E9.5. At this time, Shh is initially broadly expressed in ventral hypothalamic 
progenitors and then rapidly downregulated in the ventral midline at the level of the 
tuberal hypothalamus (Manning et al., 2006; Trowe et al., 2013). As a result, Shh is 
expressed in bilateral stripes adjacent to the ventral midline, unlike in spinal cord and 
hindbrain regions where Shh is restricted to the floor plate (Echelard et al., 1993). Our 
lab suggested this process is also mediated by Bmp signaling. Though the exact 
mechanism is unclear, Bmp signaling induces Tbx3 expression in the ventral midline. 
Tbx3 binds Sox2, interfering with the ability of Sox2 to activate the expression of Shh 
(Zhao et al., 2012; Trowe et al., 2013). Moreover, neural progenitors immediately dorsal 
to the bilateral stripes of Shh are responsive to Shh signaling, indicated by Gli1 
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expression, whereas progenitors located in the ventral midline remain refractory to Shh 
signaling (Ohyama et al., 2008). 
One additional factor which may serve to distinguish the role of Shh in patterning 
of the hypothalamus from other areas of the central nervous system is Low-density 
lipoprotein receptor-related protein 2 (Lrp2). Biochemical and in vivo studies of Lrp2 
function have revealed Lrp2 is able to bind both Shh (as a co-receptor) and Bmp4 (as a 
scavenger receptor) (McCarthy et al., 2002; Spoelgen et al., 2005; Christ et al., 2012). 
Thus, Lrp2 may act to regulate a balance between Shh and Bmp signaling in the ventral 
midline of the hypothalamus. 
 
 
Mis-regulation of Shh in the hypothalamus: 
The hypothalamus is particularly sensitive to proper levels of Shh signaling 
during development. A loss of this prechordal source of Shh results in a brain 
malformation termed Holoprosencephaly (HPE). As shown in Shh null mice, the 
prechordal source of Shh is necessary to drive the separation of the cerebral 
hemispheres, eye fields, and craniofacial structures (Chiang et al., 1996). This 
prechordal source of Shh is further required for the induction of the hypothalamic 
territory (Chiang et al., 1996; Dale et al., 1997). To circumvent this loss of hypothalamic 
tissue, conditional approaches were used to target and identify roles for the forebrain 
source of Shh. Foxb1-mediated recombination ablated Shh expression throughout the 
ventral forebrain. This model left the prechordal source of Shh intact. The prechordal 
plate and its source of Shh were sufficient to specify the hypothalamic territory, marked 
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by Nkx2.1, but not the identity of neuronal progenitors (Szabó et al., 2009) within the 
tuberal hypothalamus. 
However, in these experiments, additional forebrain sources of Shh were also 
disrupted. Thus, our lab developed an SBE2-cre is a transgenic mouse line that uses 
Shh brain enhancer 2 (SBE2) to activate cre transcription in the ventral diencephalon in 
a similar pattern to the endogenous expression of Shh. This model allowed for the 
selective deletion of Shh in the ventral diencephalon of Shh∆hyp embryos by E9.0. These 
ShhΔhyp mutants display optic nerve and pituitary defects with similarities to SOD in 
humans (Zhao et al., 2012). The eye and pituitary develop in close proximity to the 
source of SHH in the anterior hypothalamus. However, loss-of-function mutations in 
SHH have not been associated with SOD in human patients (Paulo et al., 2015; Gregory 
et al., 2015). Previous work in our lab thus sought to examine whether SOD may 
represent a malformation with a later manifestation compared to HPE. Specifically, HPE 
and SOD may be differentiated by the timing and location of disruption in SHH signaling, 
with an early loss of SHH from the prechordal plate giving rise to HPE, and a slightly 
later absence of SHH from the presumptive hypothalamus resulting in SOD. 
Furthermore, Shh and Gli1 continue to be expressed beyond the stage when 
tuberal hypothalamic progenitors first acquire their identity and their expression extends 
into the peak period of DMH, VMH and ARC neurogenesis between E12.5 and E14.5. 
The experiments presented in the following chapters sought to further describe roles for 
the various temporal windows of dynamic Shh expression and signaling in hypothalamic 
development. 
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Chapter 1 Figures
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Figure 1. Location and organization of the hypothalamus.  
(A) Schematic of the adult mouse brain highlighting the location of the hypothalamus in 
blue. The four subdivisions of the hypothalamus along the rostrocaudal axis are the 
preoptic area, the anterior hypothalamus, the tuberal hypothalamus, and the mammillary 
hypothalamus. (B) Diagram depicting the nuclei in a cross-section through the tuberal 
hypothalamus. Characteristic gene expression markers of the various nuclei are color 
coded. From ventral to dorsal- the arcuate nucleus (ARC), ventrhomedial hypothalamic 
nucleus (VMH) and the dorsomedial hypothalamic nucleus (DMH). 
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Figure 2. Subdivisions of the Ventromedial Hypothalamus (VMH) and associated 
gene expression. 
The VMH can be subdivided into dorsomedial (DM), central (C), and ventrolateral (VL) 
compartments. Each compartment is associated with the expression of specific 
transcription factors or receptors for neuropeptides or hormones including steroidogenic 
factor-1 (SF-1), brain-derived neurotrophic factor (BDNF), estrogen receptor alpha 
(ERa), leptin receptor (LepR), or insulin receptor (IR). 
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CHAPTER 2: Prenatal ethanol exposure in mice phenocopies Cdon 
mutation by impeding Shh function in the etiology of optic nerve 
hypoplasia 
 
Benjamin M. Kahn, Tanya S. Corman, Korah Lovelace, Mingi Hong, Robert S. Krauss, 
and Douglas J. Epstein 
 
Abstract 
Septo-optic dysplasia (SOD) is a congenital disorder characterized by optic nerve, 
pituitary and midline brain malformations. The clinical presentation of SOD is highly 
variable with a poorly understood etiology. The majority of SOD cases are sporadic, but 
in rare instances inherited mutations have been identified in a small number of 
transcription factors, some of which regulate the expression of Sonic hedgehog (Shh) 
during mouse forebrain development. SOD is also associated with young maternal age, 
suggesting that environmental factors, including alcohol consumption at early stages of 
pregnancy, might increase the risk of developing this condition. Here, we address the 
hypothesis that SOD is a multifactorial disorder stemming from interactions between 
mutations in Shh pathway genes and prenatal ethanol exposure. Mouse embryos with 
mutations in the Shh co-receptor, Cdon, were treated in utero with ethanol or saline at 
embryonic day 8 (E8.0) and evaluated for optic nerve hypoplasia (ONH), a prominent 
feature of SOD. We show that both Cdon−/− mutation and prenatal ethanol exposure 
independently cause ONH through a similar pathogenic mechanism that involves 
selective inhibition of Shh signaling in retinal progenitor cells, resulting in their premature 
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cell-cycle arrest, precocious differentiation and failure to properly extend axons to the 
optic nerve. The ONH phenotype was not exacerbated in Cdon−/− embryos treated with 
ethanol, suggesting that an intact Shh signaling pathway is required for ethanol to exert 
its teratogenic effects. These results support a model whereby mutations in Cdon and 
prenatal ethanol exposure increase SOD risk through spatiotemporal perturbations in 
Shh signaling activity. 
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Introduction 
Septo-optic dysplasia (SOD) is a clinically heterogeneous disorder that is 
diagnosed on the presence of at least two of the following conditions: optic nerve 
hypoplasia (ONH), hypopituitarism and absence of the septum pellucidum (Webb and 
Dattani, 2010). The severity of these features varies widely in SOD, which has an 
incidence of 1 in 10,000 live births (Patel et al., 2006). ONH is the most common finding 
in SOD, and manifests as a thinning of the optic nerve as it exits the eye, resulting in 
insufficient photo-transduction to the brain and, in many instances, blindness (Morishima 
and Aranoff, 1986; Cemeroglu et al., 2015). Variable pituitary dysfunction, including 
isolated growth hormone deficiency, central hypothyroidism, and panhypopituitarism is 
also observed in individuals with SOD, with decreased levels of one or more pituitary 
hormones being diagnosed by two years of age (Cemeroglu et al., 2015). Cognitive 
delay and seizure disorders are also frequently seen in SOD. 
The cause of SOD is poorly understood. Most cases are idiopathic, but in rare 
instances (<1%) inherited mutations have been described in a small number of 
transcription factors (SOX2, SOX3, HESX1, OTX2, TCF7L1) expressed during 
embryonic brain development (McCabe et al., 2011; Gaston-Massuet et al., 2016). The 
high phenotypic variability, coupled with its sporadic nature, suggest that SOD might be 
influenced by a combination of environmental and genetic factors. 
Insight into the pleiotropic nature of the SOD phenotype was recently realized 
from the study of a conditional mouse mutant lacking Shh in the developing 
hypothalamus (ShhΔhyp). ShhΔhyp mutants display optic nerve and pituitary defects with 
similarities to SOD in humans (Zhao et al., 2012). The eye and pituitary develop in close 
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proximity to the source of SHH in the anterior hypothalamus and depend on this signal 
for formation of the optic disc, from where the optic nerve exits the eye, and for 
coordinating pituitary morphogenesis. These findings raise the possibility that reduced 
SHH expression and or signaling activity from the hypothalamus might underlie the 
pathogenesis of SOD in humans. In support of this hypothesis, SOX2 and SOX3 – two 
SOD-associated genes – were shown to be dose-dependent regulators of SHH 
transcription that directly bind and activate a long-range SHH forebrain enhancer (Zhao 
et al., 2012). 
Nonetheless, loss-of-function mutations in SHH are not associated with SOD 
(Paulo et al., 2015; Gregory et al., 2015), but instead are known to cause another brain 
malformation, holoprosencephaly (HPE), with partially overlapping features to SOD 
(Roessler et al., 1996). HPE results from imperfect separation of the cerebral 
hemispheres and craniofacial structures as a result of reduction in SHH signaling from 
the prechordal plate, a transient embryonic tissue required for early aspects of forebrain 
development, including the specification of the hypothalamic territory (Chiang et al., 
1996). Therefore, HPE and SOD could be distinguished by the timing and location of 
SHH signal disruption, with an early loss of SHH from the prechordal plate giving rise to 
HPE, and a slightly later absence of SHH from the presumptive hypothalamus resulting 
in SOD. 
The SHH pathway has many roles during eye development. Early functions 
include separation of the eye fields and patterning of the optic cup (Chiang et al., 1996). 
At later stages, Shh secreted from retinal ganglion cells (RGCs) controls the proliferation 
of multipotent retinal progenitor cells (RPCs), the timing of their differentiation, as well as 
the guidance of RGC axons out of the eye (Wang et al., 2005; Kolpak et al., 2005; 
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Sanchez-Camacho and Bovolenta, 2008; Stacher Hörndli and Chien, 2012). Mice 
lacking Shh in RGCs display ONH resulting from a failure in optic disc formation 
(Dakubo et al., 2003). Thus, ONH can arise by interfering with SHH signaling from two 
independent sources, anterior hypothalamus and RGCs, at distinct stages of eye 
development. 
Epidemiological studies indicate that SOD associates with young maternal age 
and primiparity (Haddad and Eugster, 2005; Murray et al., 2005; Garcia-Filion and 
Borchert, 2013; Cemeroglu et al., 2015). How these risk factors contribute to the etiology 
of SOD is unknown, but they might be linked to adverse maternal behavior during early 
stages of pregnancy (Garcia-Filion and Borchert, 2013). For instance, several clinical 
features of fetal alcohol syndrome overlap with HPE and SOD, suggesting that prenatal 
ethanol exposure might increase the risk of both conditions, depending on the timing of 
the insult (Sulik et al., 1981; Strömland, 1987; Coulter et al., 1993; Ashwell and Zhang, 
1994; Blader and Strähle, 1998; Hellström, 1999; Ribeiro et al., 2007; Aoto et al., 2008; 
Loucks and Ahlgren, 2009; Lipinski et al., 2010, 2012; Zhang et al., 2011). 
The SHH signaling pathway is a key target of prenatal ethanol exposure and its 
perturbation explains much of the HPE-like phenotype observed in animal models of this 
condition (Ahlgren et al., 2002; Li et al., 2007; Higashiyama et al., 2007; Aoto et al., 
2008). Interestingly, mouse embryos with mutations in Shh pathway genes that have no, 
or minimal, phenotypic consequence on their own, show a profound increase in the 
penetrance and severity of HPE when exposed to sub-teratogenic doses of ethanol 
(Hong and Krauss, 2012; Kietzman et al., 2014). The synergy between these genetic 
and environmental risk factors for HPE is dependent on the timing of ethanol 
administration during pregnancy, with a strong interaction observed at embryonic day 7 
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(E7.0), coinciding with a disruption in Shh signaling from the prechordal plate (Hong and 
Krauss, 2012). 
On the basis of these studies, we postulate that SOD is a multifactorial condition 
that results from interactions between genetic and environmental risk factors acting at 
slightly later stages of forebrain development than those that cause HPE. To test this 
hypothesis and better define the relationship between ethanol intake, Shh signaling and 
SOD, we examined eye development in mouse embryos with mutations in the Shh co-
receptor, Cdon, that were exposed in utero to either ethanol or saline at E8.0. Wild--type 
embryos treated with ethanol phenocopied Cdon−/− mutants treated with saline in the 
manifestation of ONH by selectively impeding Shh signaling activity in RPCs. The 
combination of Cdon mutation and ethanol exposure did not worsen the ONH 
phenotype, indicating that this gene–environment interaction is not additive or 
synergistic. These results support a model whereby mutations in Cdon and prenatal 
ethanol exposure are risk factors for SOD and HPE through temporally and spatially 
distinct perturbations in Shh signaling activity. 
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Results 
We followed a previously validated protocol for prenatal ethanol exposure (see 
Materials and Methods) to determine whether Cdon−/− embryos were sensitive to 
ethanol-induced ONH, a prominent feature of SOD. All mice described in this study were 
maintained on a 129S6/SvEvTac genetic background, which is largely impervious to the 
HPE-associated phenotypes caused by Cdon mutation or ethanol exposure observed in 
other mouse strains (Zhang et al., 2006; Downing et al., 2009; Hong and Krauss, 2012). 
Pregnant Cdon+/− females that were time-bred with Cdon+/− males received 
intraperitoneal injections of ethanol (3.48 g/kg) or saline at E8.0 and again four hours 
later. This embryonic stage was chosen because it was subsequent to the HPE-critical 
period at E7.0, allowing us to address the temporal specificity of gene–environment 
interactions in the etiology of SOD. 
Cdon mutation and prenatal ethanol exposure independently cause ONH 
Cdon is expressed at early stages of eye development (E9-E11.5), including 
progenitors of the neural retina and lens vesicle (Zhang et al., 2009). Cdon−/− and wild-
type embryos were harvested at E14.5, cryo-sectioned along the coronal plane of their 
heads, and immunostained for neurofilament. No gross abnormalities in the size or 
structure of the brain were observed between wild-type and Cdon−/− embryos in either 
the ethanol or saline treatment groups. Moreover, none of the prominent eye defects 
displayed by Cdon−/− mutant embryos on the C57BL/6 genetic background, including 
coloboma, microphthalmia and lens dysmorphology (Zhang et al., 2009) were detected 
in any of the 129S6 embryos (129S6.Cdon−/−), consistent with the strain specificity of 
these phenotypes. 
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To assess the embryos for ONH, the diameter of the optic nerve was measured 
at the level of the optic disc. Cdon−/− embryos treated with saline showed a 39% 
reduction in optic nerve diameter (mean±s.d., 32.26±1.83 μm, n=9, P<0.001) compared 
with control littermates (52±3.47 μm, n=8) (Fig. 3A,B,E). This difference was significant 
after normalizing for eye size (Fig. 3F-H). Wild--type embryos exposed to ethanol 
showed a similar reduction in optic nerve diameter (29.7±2.14 μm, n=9, P<0.001) 
compared with saline-treated controls (Fig. 3A,C). This result was unexpected given that 
129S6 embryos were thought to be resistant to ethanol-mediated teratogenicity 
(Downing et al., 2009; Hong and Krauss, 2012), although the optic nerve was not 
examined in these prior studies. The combination of Cdon mutation and prenatal ethanol 
exposure did not exacerbate the ONH phenotype compared with embryos with either 
condition alone. Ethanol-treated Cdon−/− embryos showed a 37% decrease in optic 
nerve width (33±2.4 μm, n=8, P<0.001) compared with saline--treated controls (Fig. 
3A,D), which was a similar reduction to that seen in saline-treated Cdon−/− embryos and 
ethanol-treated wild-type embryos (Fig. 3A-E). These data indicate that Cdon mutation 
and prenatal ethanol exposure both contribute to the etiology of ONH and that additional 
risk factors, such as genetic background (129S6 versus C57BL/6) and timing of ethanol 
exposure (E7.0 versus E8.0), influence the phenotypic outcome of ONH versus HPE. 
Formation of the optic disc is not disturbed in Cdon−/− and ethanol-exposed 
embryos 
The optic nerve exits the eye through the optic disc, which forms at the juncture 
of the optic stalk and cup. ONH can arise from defects in optic disc formation or from a 
deficit in the number of RGC axons that make up the optic nerve (Deiner et al., 1997; 
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Dakubo et al., 2003; Zhao et al., 2012). To distinguish between these two possibilities, 
we evaluated the expression of Pax2 in the optic disc of Cdon−/− and wild-type embryos 
that were exposed in utero to either saline or ethanol at E8.0 of gestation. No significant 
differences were observed between the number of Pax2+ cells in embryos from the 
experimental and control groups (Fig. 4), thus excluding major defects in optic disc 
formation as a likely explanation for the ONH phenotype in either of these mouse 
models. 
Shh-dependent proliferation of RPCs is compromised in Cdon−/− and ethanol-
treated embryos 
The absence of a synergistic interaction between Cdon−/− mutation and prenatal 
ethanol exposure in the manifestation of ONH suggested that both insults might be 
disrupting a common or parallel signaling pathway(s) important for eye development. 
Shh is the most likely pathway to be compromised in these mouse models of ONH given 
the established role of Cdon as a Shh co-receptor, the essential function of Shh in RPC 
proliferation, and the negative influence of ethanol on Shh pathway activation in a variety 
of developing tissues (Ahlgren et al., 2002; Wang et al., 2005; Zhang et al., 2006; 
Tenzen et al., 2006; Li et al., 2007; Aoto et al., 2008; McLellan et al., 2008; Allen et al., 
2011; Hong and Krauss, 2013). 
To evaluate the integrity of Shh signaling we assessed Gli1 expression, a reliable 
readout of Shh pathway activation (Marigo et al., 1996), on sections through the eye at 
E14.5. Wild-type embryos treated with saline showed robust expression of Gli1 in the 
RPC layer of the developing eye at E14.5 (Fig. 5A). In comparison, Gli1 was markedly 
reduced in the RPCs of wild-type and Cdon−/− embryos exposed to ethanol at E8.0, as 
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well as Cdon−/− embryos treated with saline (Fig. 5A-D). The downregulation of Gli1 
seemed to be specific to the eye as an adjacent domain of expression in the anterior 
hypothalamus was unaffected across genotypes and treatment groups (Fig. 5E-H). 
Moreover, Shh expression was not compromised in the eye or hypothalamus of any of 
the embryos (Fig. 5I-P), suggesting that both Cdon mutation and prenatal ethanol 
exposure were acting directly on some aspect of RPC development downstream of Shh. 
Shh signaling maintains RPCs in a mitotically active state until they are poised to 
differentiate into RGCs (Zhang and Yang, 2001; Wang et al., 2005). Therefore, we next 
determined whether the downregulation in Shh signaling observed in Cdon−/− and 
ethanol-treated embryos compromised the growth and differentiation properties of 
RPCs. The proliferation marker Ki67 labeled 670 RPCs per section (n=3) in saline--
treated wild-type embryos at E14.5 (Fig. 6A,I). By contrast, a drastic reduction in the 
number of Ki67-positive RPCs was observed in Cdon−/− embryos treated with ethanol 
(88 RPCs/section, n=3, P<0.001) or saline (117 RPCs/section, n=3, P<0.001), as well as 
wild-type embryos exposed to ethanol (113 RPCs/section, n=3, P<0.001) (Fig. 6A-D,I). 
Despite the significant reduction in Ki67 staining, trace amounts were still detected in 
Cdon−/− and ethanol-treated embryos upon increased exposure times. Reduced 
proliferation was also noted in the lens epithelium of Cdon−/− and ethanol-treated 
embryos (Fig. 6J), as described previously (Zhang et al., 2009). The proliferation defects 
seem to be specific to the eye as no significant differences were detected in the number 
of Ki67-positive neural progenitors in adjacent brain regions from either genotype or 
treatment group (Fig. 6E-H,K). These results suggest that the failure of RPCs to respond 
to Shh signaling in both Cdon−/− and ethanol-treated embryos at E8.0 compromises their 
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ability to replicate, in agreement with other studies of Shh signaling in the eye (Wang et 
al., 2005).  
Precocious differentiation of RGCs in Cdon−/− and ethanol-treated embryos 
To determine if the differentiation of RPCs was affected by their premature cell-
cycle exit we assessed expression of Math5 (also known as Atoh7), a bHLH 
transcription factor required at the onset of RGC differentiation (Wang et al., 2001). In 
control embryos, Math5 expression was confined to postmitotic progenitors in the 
ventricular zone. By contrast, in Cdon−/− and ethanol-treated embryos, Math5 expression 
extended from the ventricular zone into the ganglion cell layer (Fig. 7A-D). This 
observation is similar to the previous report of expanded Math5 expression in mouse 
mutants that lack Shh signaling in the eye (Sakagami et al., 2009), and suggests that 
loss of Shh-dependent RPC proliferation might be associated with precocious 
differentiation of RPCs. 
RGCs are the earliest born retinal cell type originating from a subset of RPCs 
expressing Math5 (Feng et al., 2010; Brzezinski et al., 2012). The LIM homeobox 
transcription factor Isl1 functions downstream of Math5, and in conjunction with the POU 
domain protein Pou4F2 promotes RGC differentiation (Mu et al., 2008; Pan et al., 2008; 
Prasov and Glaser, 2012; Wu et al., 2015). We evaluated the status of RGC 
differentiation in Cdon−/− and ethanol-treated embryos by immunostaining for Isl1. At 
E14.5, RGCs are still early in their differentiation as evidenced by the sparse labeling of 
Isl1 in saline--treated wild-type embryos (225 cells/section, n=3) (Fig. 7E). However, the 
number of Isl1-positive cells was increased by 32% in wild-type (329 cells/section, n=3, 
P<0.05) and Cdon−/− (338 cells/section, n=3, P<0.01) embryos exposed to ethanol at 
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E8.0, as well as in saline--treated Cdon−/− mutants (349 cells/section, n=3, P<0.05) (Fig. 
7E-H,M). Although Isl1 is not exclusively expressed by RGCs, we did not observe 
significant differences in the number of other early-born retinal progenitors, such as 
amacrine cells expressing AP-2α (also known as Tfap2a), between controls and 
treatment groups, suggesting that the precocious differentiation was limited to RGCs 
(Fig. 7I-L,N). 
These data suggest that the loss of Shh signaling in Cdon−/− and ethanol-treated 
embryos results in the precocious differentiation of RGCs, which would likely deplete the 
pool of non-proliferating RPCs over time (Wang et al., 2005). The significant thinning of 
the optic nerve in experimental embryos likely results from the failure of these 
prematurely differentiating RGCs to properly extend axons to the optic disc, a premise 
that is supported by a previously characterized role for Shh in regulating the guidance of 
RGC axons (Sanchez-Camacho and Bovolenta, 2008). Taken together, our results 
demonstrate that prenatal ethanol exposure at E8.0 phenocopies 129S6.Cdon−/− mutant 
embryos in the manifestation of ONH by selective interference with Shh-dependent 
expansion and differentiation of RPCs in the eye. 
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Discussion 
Ethanol and Cdon mutation impede Shh signaling in RPCs to cause ONH 
The association of SOD with young maternal age led to the hypothesis that 
adverse behavior, including prenatal alcohol exposure, is a predisposing factor in its 
etiology (Haddad and Eugster, 2005; Murray et al., 2005; Garcia-Filion and Borchert, 
2013; Cemeroglu et al., 2015). Fetal exposure to alcohol causes a spectrum of 
developmental disorders; however, direct evidence linking ethanol to SOD has been 
lacking. Here, we used a mouse model to demonstrate that in utero exposure to ethanol 
at E8.0 causes ONH, the most prevalent SOD-associated phenotype. We show that 
ethanol causes ONH through a similar mechanism to that observed in Cdon−/− embryos, 
involving the inhibition of Shh signaling activity in retinal progenitor cells, which leads to 
their premature cell-cycle arrest, precocious differentiation, and failure to properly extend 
axons to the optic nerve (Fig. 8). 
These data are consistent with previous studies showing that Shh secreted from 
RGCs is required to maintain RPCs in a proliferative state, thus preventing their 
differentiation (Zhang and Yang, 2001; Wang et al., 2005; Sakagami et al., 2009). RGCs 
also remain dependent on Shh during their maturation, as evidenced by the axonal 
outgrowth defects that occur upon further inhibition of Shh (Kolpak et al., 2005; 
Sanchez-Camacho and Bovolenta, 2008). Taken together, our findings implicate the 
disruption of RGC-derived Shh signaling as the pathogenic mechanism by which Cdon 
mutation and prenatal ethanol exposure cause ONH (Fig. 8D). 
Interestingly, Cdon has also been reported to antagonize hedgehog (Hh) 
signaling in the optic vesicle of zebrafish and chick embryos (Cardozo et al., 2014). 
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However, we did not observe any of the gain of Hh function phenotypes described in 
Cdon morphants, including expansion of Pax2-expressing cells in the ventral retina, or 
increased Hh signaling in the hypothalamic territory adjacent to the eye. Moreover, the 
HPE phenotype displayed by Cdon−/− mouse embryos exposed to ethanol at E7.0 was 
rescued by increasing Shh signaling activity (Hong and Krauss, 2013), in contrast to the 
decrease in Hh that restored eye patterning in Cdon morphants (Cardozo et al., 2014). 
The differences between our findings and those of Cardozo et al. (2014) might be 
related to the species in which the experiments were performed, or possibly the nature 
of the genetic manipulations – germline mutation versus morpholino knockdown – that in 
some cases might result in phenotypic differences resulting from distinct modes of 
genetic compensation (Rossi et al., 2015). 
Strain-dependent modifiers and timing of prenatal ethanol exposure influence 
Shh-related phenotypes 
A particularly striking feature of our mouse model is the influence that genetic 
background and timing of prenatal ethanol exposure have on the variable phenotypic 
severity, in keeping with other studies of ethanol-induced teratogenesis (Downing et al., 
2009; Lipinski et al., 2012). When bred on the 129S6/SvEvTac strain, both Cdon−/− 
mutants and wild-type embryos exposed to ethanol at E8.0 presented with ONH. By 
contrast, when raised on a C57BL/6 (C57BL/6NTac or C57BL/6J) genetic background, 
both Cdon−/− embryos, and wild-type embryos exposed to ethanol one day earlier at 
E7.0, exhibited HPE (Zhang et al., 2006; Higashiyama et al., 2007; Aoto et al., 2008; 
Godin et al., 2010). Thus, strain-dependent modifiers of the Cdon−/− mutation and timing 
of prenatal ethanol exposure affect the spatiotemporal dynamics of Shh pathway 
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disruption in the eye and prechordal plate, which influences the likelihood of developing 
ONH versus HPE, respectively. 
It is intriguing that we did not detect any interaction between Cdon−/− mutation 
and ethanol in the manifestation of ONH, or other SOD-related phenotypes, whereas 
synergy between the two insults was observed for HPE (Hong and Krauss, 2012). This 
finding suggests that the eye is especially vulnerable to genetic and environmental 
perturbations in Shh signaling, at least on the more resistant 129S6 background. 
Pituitary hypoplasia is another prominent feature of SOD that arises from Shh pathway 
disruption (Treier et al., 2001; Wang et al., 2010; Zhao et al., 2012). However, Shh 
expression in the anterior hypothalamus, which is required for pituitary morphogenesis, 
was not affected in the embryos analyzed in our study. Hence, more impactful 
perturbations in Shh signaling might be needed to compromise pituitary development, as 
described in other mouse models of SOD (Zhao et al., 2012; Gaston-Massuet et al., 
2016). 
Effects of ethanol on Shh signaling 
Another interpretation for the inability of ethanol to worsen the ONH phenotype in 
Cdon−/− mutants is that an intact Shh signaling pathway is required for ethanol to exert 
its teratogenic effect. Ethanol treatment reduces Shh signaling through diverse 
mechanisms, including the activation of Shh pathway antagonists (PKA), repression of 
Shh pathway modulators (cholesterol), and indirect consequences that decrease the 
survival of Shh-expressing and/or responsive cells, possibly owing to increased oxidative 
stress (Ahlgren et al., 2002; Li et al., 2007; Aoto et al., 2008; Zhang et al., 2011). In each 
of these examples the acute effect of ethanol on Shh signaling is short-lived, occurring 
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close to the developmental stage when Shh function is required. However, in our study 
Shh is not expressed in the eye until several days after ethanol administration, 
suggesting that ethanol-induced alterations persist beyond the time of exposure. 
One potential mechanism by which ethanol might invoke long-lasting changes in 
gene expression is through epigenetic modifications of DNA and chromatin structure 
(Kleiber et al., 2014). Acetyl-CoA is an end product of ethanol metabolism and, among 
its many cellular functions, serves as a substrate for histone acetylation. Stable 
alterations in the acetylation and methylation of histone tails at several loci were 
detected in the cerebral cortex of E17 mouse embryos after in utero ethanol exposure at 
E7.0 (Veazey et al., 2015). Whether these ethanol-induced changes in histone 
modifications alter gene expression programs that are responsible for specific 
developmental defects requires further experimentation. Nonetheless, these 
observations suggest an intriguing model in which prenatal ethanol exposure at E8.0 
perturbs the epigenetic landscape leading to alterations in Shh-dependent gene 
expression in the eye at E14.5 (Fig. 8C). 
SOD is a multifactorial disorder 
The idiopathic nature of most SOD cases suggests a multifactorial etiology to this 
debilitating condition, including sporadic mutations and environmental teratogens that 
impinge on Shh-dependent mechanisms of eye and pituitary development. Exome and 
whole-genome sequencing of SOD cases should assist in the identification of as-yet 
undiscovered genetic variants that increase disease risk. Although our study 
demonstrated the adverse effects of prenatal ethanol exposure on Shh signaling during 
eye development, other drugs, including cannabinoids and their more potent synthetic 
29 
 
derivatives, might also contribute to disease pathogenesis by interfering with Shh signal 
transduction at key stages of embryonic development (Khaliullina et al., 2015; Gilbert et 
al., 2015). The use of drugs and alcohol at early stages of pregnancy is particularly 
harmful to the embryo because it coincides with a sensitive period of brain development 
during the first month when young mothers are often unaware of their pregnancy. A 
better understanding of the gene–environment interactions underlying SOD risk might 
improve treatment options, time to diagnosis, and public awareness of the importance 
for early prenatal care, even when pregnancy is inadvertent. 
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Materials and Methods 
Mice 
All animal work was approved by the Institutional Animal Care and Use Committee 
(IACUC) at the Icahn School of Medicine at Mount Sinai and the Perelman School of 
Medicine, University of Pennsylvania. The animal facilities at both institutions are 
accredited by the Association for Assessment and Accreditation of Laboratory Animal 
Care International (AAALAC). Detailed methods for all mouse breeding experiments, in 
utero ethanol administration, measurements of maternal blood alcohol concentration and 
embryo harvest are described in Hong and Krauss (2012). Briefly, Cdon+/− mice on a 
129S6/SvEvTac (129S6) background were mated for one hour in the dark and checked 
for the presence of a vaginal plug. The time of plug detection was designated as 
embryonic day 0 (E0). Pregnant female mice were injected intraperitoneally with 15 μl/g 
body weight of a solution of 30% ethanol in saline (3.48 g/kg) at E8.0, and again 4 h 
later. Saline injections were used as a control. Generation of mice with a targeted Cdon 
null allele was described previously (Cole and Krauss, 2003). 
 
Immunohistochemistry and in situ hybridization 
Embryos were harvested at E14.5, fixed overnight in 4% paraformaldehyde at 4°C, 
washed in PBS, dehydrated through a graded ethanol series, and stored in 100% 
ethanol at −20°C. Embryos were rehydrated in PBS, cryoprotected in 30% sucrose 
overnight at 4°C, embedded in Tissue-Tek OCT Compound (Sakura Finetek USA, Inc., 
Torrance, CA), quick-frozen on dry ice, and cryosectioned at 16 µm. Primary antibodies 
used for immunohistochemistry and their dilutions are as follows: mouse anti-
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neurofilament (1:250, 2H3), mouse anti-islet1/2 (1:100, 39.4D5), mouse anti AP-2alpha 
(1:100, 5E4) were obtained from Developmental Studies Hybridoma Bank (University of 
Iowa, Iowa City, IA); rabbit anti-Pax2 (1:250, 71-6000, Invitrogen); mouse anti-Ki67 
(1:1000, ACK02, Leica Biosystems). Detection of primary antibodies was achieved using 
secondary antibodies conjugated to Cy3 (1:100, 115-106-006, Jackson 
ImmunoResearch Laboratories) or Alexa 488 (1:100, A32723, Molecular Probes). 
Section in situ hybridization was performed with digoxygenin-UTP-labeled riboprobes 
essentially as described (Nissim et al., 2007). At least three to five embryos in the 
experimental and control groups were evaluated for each antibody or in situ probe. 
 
Quantification and statistical analysis 
All cell counts were performed using the cell counter function in ImageJ (NIH) on tissue 
sections from at least three embryos of each experimental and control group. The width 
of the optic nerve was determined at its mid-point using image software in the Leica 
Application Suite (Leica Microsystems). The axial width and length of each eye was also 
determined. Eye measurements were taken from at least eight embryos of each 
experimental and control group that were blind to the observer. Statistical analysis was 
performed in GraphPad Prism using the Student's t-test. 
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Chapter 2 Figures 
 
Figure 3. Cdon mutation and ethanol exposure independently cause optic nerve 
hypoplasia.  
(A-D) Immunostaining for neurofilament (green) on transverse sections through the eye 
at E14.5 labels the optic nerve (arrow). Compared with (A) saline-treated wild-type 
(Cdon+/+) embryos (n=9), the diameter of the optic nerve (white line) is significantly 
reduced in (B) saline-treated Cdon−/− mutants (n=8), (C) ethanol-treated wild-type 
embryos (n=9), and (D) ethanol-treated Cdon−/− mutants (n=9). Scale bar: 200 µm. (E-
H) Quantification of (E) optic nerve diameter, (F) axial length of eye, (G) axial width of 
eye, and (H) optic nerve diameter (OND) normalized to axial width (AW) of the eye. Error 
bars represent s.d. **P<0.01, ***P<0.001 by Student's t-test 
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Figure 4. The optic disc is not compromised in Cdon−/− or ethanol-treated 
embryos.  
(A-D) Immunostaining for Pax2 on transverse sections through the eye at E14.5 marks 
the optic disc (arrows). No significant differences were observed in the average number 
of Pax2+ optic disc cells per section from (A) saline-treated wild-type (Cdon+/+) embryos 
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(n=6), (B) saline-treated Cdon−/− mutants (n=8), (C) ethanol-treated wild-type embryos 
(n=8), and (D) ethanol-treated Cdon−/− mutants (n=8). Scale bar: 200 µm. (E) 
Quantification of Pax2+ optic disc cells. Error bars represent s.d. Student's t-test. 
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Figure 5. Selective reduction of Gli1 expression in the eyes of Cdon−/− and ethanol-
treated embryos. 
In situ hybridization for Gli1 (A-H), and Shh (I-P) on transverse sections through the eye 
(A-D,I-L) and hypothalamus (E-H,M-P) of E14.5 wild-type (Cdon+/+) and Cdon−/− embryos 
treated with saline or ethanol at E8.0. Gli1 expression is detected in retinal progenitor 
cells (RPCs, area marked by dotted white line) of (A) saline-treated wild-type embryos 
(n=5). Gli1 expression is markedly reduced in RPCs of (B) saline-treated Cdon−/− 
mutants (n=5), (C) ethanol-treated wild-type embryos (n=9), and (D) ethanol-treated 
Cdon−/− mutants (n=5). No differences were observed in the expression of Gli1 in the 
hypothalamus between genotypes or treatment groups (E-H). No differences were 
observed in the level of Shh expression in retinal ganglion cells (RGCs, area marked by 
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dotted black line, I-L) or the hypothalamus (M-P) between genotypes or treatment 
groups. Scale bar: 200 µm. 
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Figure 6. Reduced proliferation of RPCs in Cdon−/− and ethanol-treated embryos.  
(A-H) Immunostaining for Ki67 on transverse sections through the eye (A-D) and 
hypothalamus (E-H) of E14.5 embryos labels proliferating progenitors. (A) The majority 
of retinal progenitor cells (RPCs, area marked by dotted white line) in saline-treated wild-
type (Cdon+/+) embryos (n=3), are marked by Ki67. The number of Ki67+ RPCs is 
significantly reduced in (B) saline-treated Cdon−/− embryos (n=3), (C) ethanol-treated 
wild-type embryos (n=3), and (D) ethanol-treated Cdon−/− embryos (n=3). No differences 
in the number of Ki67+ cells in the ventricular layer of the ventral hypothalamus (boxed 
area) were observed between genotypes or treatment groups (E-H). Scale bar: 200 µm. 
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(I-K) Quantification of Ki67+ cells in (I) retina, (J) lens and (K) hypothalamus sections 
across all experimental groups. Error bars represent s.d. *P<0.05, **P<0.01, ***P<0.001 
by Student's t-test. 
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Figure 7. Precocious differentiation of RGCs in Cdon−/− and ethanol-treated 
embryos.  
(A-D) In situ hybridization for Math5 on transverse sections through the eye at E14.5 
labels postmitotic progenitors in the ventricular zone (vz) of control embryos (n=3) (A). 
Math5 expression expands into the ganglion cell layer (gcl) of Cdon−/− and ethanol-
treated embryos (n=3 for each experimental group) (B-D). Dashed line marks the vz–gcl 
boundary. (E-H) Immunostaining for Isl1/2 on transverse sections through the eye of 
E14.5 embryos primarily labels differentiating retinal ganglion cells (RGCs, arrows). 
Compared with (E) saline-treated wild-type (Cdon+/+) embryos (n=3), the number of 
Isl1/2+ RGCs is significantly increased in (F) saline-treated Cdon−/− mutants (n=3), (G) 
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ethanol-treated wild-type embryos (n=3), and (H) ethanol-treated Cdon−/− mutants (n=3). 
(I-L) Immunostaining for AP-2α in amacrine cells. No significant differences were 
observed between the average number of AP-2α+ amacrine cells per section from (I) 
saline-treated wild-type (Cdon+/+) embryos (n=4), (J) saline-treated Cdon−/− mutants 
(n=3), (K) ethanol-treated wild-type embryos (n=4), and (L) ethanol-treated Cdon−/− 
mutants (n=3). Scale bar: 50 µm. (M,N) Quantification of cells expressing Isl1/2 (M) and 
AP-2α (N). Error bars represent s.d. *P<0.05, **P<0.01 by Student's t-test. 
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Figure 8. Model depicting the influence of Cdon mutation and ethanol exposure on 
Shh signaling activity in the developing eye.  
(A) In wild-type embryos (E14.5), the binding of Shh to Cdon and Ptch1 releases the 
inhibition on smoothened (Smo), facilitating the transcription by Gli activator (GliA) of 
target genes involved in RPC proliferation. (B) In the eyes of 129S6.Cdon−/− embryos, 
there is persistent inhibition of Smo by Ptch1, even in the presence of Shh, causing Gli 
repressor (GliR) to block transcription of genes involved in RPC proliferation, resulting in 
precocious RPC differentiation. (C) Ethanol exposure at E8.0 interferes with Shh 
signaling in the eye through a variety of proposed mechanisms. The lengthy delay 
between ethanol exposure (E8.0) and its negative effects on Shh signaling activity 
(E14.5), suggests that the epigenetic landscape of Shh target genes might be modified 
42 
 
to suppress RPC proliferation. (D) Cdon mutation or ethanol exposure at E8.0 impedes 
Shh signaling activity in RPCs resulting in optic nerve hypoplasia. 
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Abstract 
Roles for the secreted morphogen, Sonic hedgehog (Shh), have been well characterized 
in several brain and spinal cord regions. However, the hypothalamus has presented a 
particular challenge owing to its complex anatomy and neuronal heterogeneity. Here, we 
utilize fate-mapping and conditional deletion models in mice to define requirements for 
dynamic Shh activity at distinct stages of tuberal hypothalamic development, a brain 
region with important homeostatic functions. Tuberal hypothalamic nuclei are dependent 
on early roles for Shh in dorsoventral patterning, neurogenesis and restricting ventral 
midline area. Fate mapping experiments demonstrate that Shh expressing and 
responsive progenitors contribute to distinct neuronal subtypes, accounting for some of 
the cellular heterogeneity in tuberal hypothalamic nuclei. Conditional deletion of the 
Hedgehog transducer Smoothened (Smo), after dorsoventral patterning has been 
established, reveals that Shh signaling is necessary to maintain proliferation and 
progenitor identity during peak periods of hypothalamic neurogenesis. We also find that 
mosaic disruption of Smo causes a non-cell autonomous gain in Shh signaling activity in 
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neighboring wild type cells, suggesting a possible mechanism for the growth of 
hypothalamic hamartomas, a benign tumor that forms at fetal stages of hypothalamic 
development. 
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Introduction 
The hypothalamus is an ancient brain region with important roles in the 
regulation of several homeostatic processes and animal behaviors. Neural circuits 
mapping to distinct areas of the hypothalamus control a variety of essential bodily 
functions, including food intake, energy expenditure, fluid balance, temperature 
regulation, wakefulness, daily rhythms, as well as social behaviors associated with 
reproduction, aggression, arousal, and stress (Saper and Lowell, 2014; Zha and Xu, 
2015; Hashikawa et al., 2017; Tan and Knight, 2018). Organized into small clusters of 
neurons, termed nuclei, the hypothalamus is unlike other regions of the central nervous 
system (CNS) that are typically arranged in cell layers (Shimada and Nakamura, 1973; 
Altman and Bayer, 1986). Further adding to this complex architecture, most 
hypothalamic nuclei are composed of diverse neuronal cell types with opposing or 
sometimes unrelated functions. The developmental mechanisms regulating neuronal 
heterogeneity within hypothalamic nuclei are poorly understood compared to other CNS 
regions (Bedont et al., 2015; Burbridge et al., 2016; Xie and Dorsky, 2017). 
The hypothalamus derives from the ventral diencephalon and can be divided into 
four principal regions from rostral to caudal: preoptic, anterior, tuberal, and mammillary. 
Within the tuberal hypothalamus, neurons in the arcuate nucleus (ARC), ventromedial 
hypothalamic nucleus (VMH), dorsomedial hypothalamic nucleus (DMH), and 
paraventricular nucleus (PVN) integrate sensory information from the environment in 
order to illicit autonomic, endocrine and behavioral responses that maintain vital set 
points in the animal or adapt to various stressors (Saper and Lowell, 2014). In addition to 
receiving inputs from other brain regions, the positioning of the tuberal hypothalamus 
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offers unique exposure to peripheral cues carried through the bloodstream which are 
presented to neurons at the median eminence. 
Recent advances have been made in our understanding of the neuronal circuitry 
and function of tuberal hypothalamic nuclei. This is particularly true for the VMH, an 
elliptical shaped nucleus located above the ARC and below the DMH (Fig. 9). The VMH 
is subdivided into ventrolateral (VMHVL), central (VMHC) and dorsomedial (VMHDM) 
regions, each with distinguishable gene expression profiles (Segal et al., 2005; 
McClellan et al., 2006; Kurrasch et al., 2007). Genetic, pharmacogenetic and 
optogenetic approaches have further delineated VMH neurons into functionally distinct 
categories. ERα-expressing neurons in the VMHVL regulate sexually dimorphic features 
related to energy expenditure, reproductive behavior and aggression (Lin et al., 2011; 
Lee et al., 2014; Correa et al., 2015). Whereas, insulin receptor (IR) expressing neurons 
in the VMHC and Leptin Receptor (LEPR) neurons in the VMHDM effect body weight 
regulation in both males and females (Dhillon et al., 2006; Klöckener et al., 2011). 
Steroidogenic factor 1 (SF1, officially designated Nr5a1) neurons in the VMHDM also 
influence behavioral responses to fear and anxiety (Silva et al., 2013; Kunwar et al., 
2015). 
Despite the progress in assigning function to VMH neurons, we still know 
relatively little about how this nucleus forms and the process by which its subdivisions 
are established. During hypothalamic development, Nr5a1 is selectively expressed by all 
VMH neurons soon after they exit the cell cycle and undergo neurogenesis (Tran et al., 
2003). Nr5a1 is required for the terminal differentiation of VMH neurons, as well as their 
coalescence into a nucleus with a distinct cytoarchitecture (Ikeda et al., 1995; Davis et 
al., 2004; Büdefeld et al., 2011). Consequently, mice lacking Nr5a1 in the VMH are 
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obese, anxious, and infertile (Majdic et al., 2002; Zhao et al., 2008; Kim et al., 2010). 
Additional cell type specific factors acting upstream of Nr5a1 remain to be identified. 
One signaling molecule that may help bridge the gap in knowledge concerning 
the ontogeny of VMH neurons is Sonic Hedgehog (Shh). Shh has been studied in 
several spatial and temporal contexts related to hypothalamic development. Shh 
signaling from the prechordal plate, which underlies the ventral forebrain at early stages 
of its development, is required for the induction of the hypothalamic territory (Chiang et 
al., 1996; Dale et al., 1997). The conditional deletion of Shh in the ventral diencephalon 
causes defects in the patterning, regionalization and formation of ventral hypothalamic 
nuclei (Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012; Carreno et al., 
2017). Nevertheless, the pathogenic mechanisms underlying these Shh dependent 
alterations in hypothalamic development have yet to be fully realized. Moreover, since 
Shh continues to be expressed in VMH progenitors well beyond the initial patterning 
stage, additional roles for Shh in VMH nucleogenesis and neuronal subtype identity are 
likely (Alvarez-Bolado et al., 2012). 
Here, we use conditional knockout mice to interrogate the functional 
requirements of Shh signaling at specific periods of hypothalamic development. We 
show that the pronounced loss of hypothalamic nuclei that manifests from the early 
deletion of Shh at embryonic day 9 (E9.0) is caused by defects in dorsoventral 
patterning, neurogenesis and the expansion of ventral midline cells, indicating a novel 
role for Shh in restricting ventral midline development in the tuberal hypothalamus. Fate 
mapping experiments reveal that Shh expressing and Shh responsive cell lineages are 
enriched in distinct domains of the VMH, contributing to the neuronal heterogeneity of 
this nucleus. The deletion of Smoothened (Smo), an essential transducer of Shh 
48 
 
signaling, at later stages of hypothalamic development (after E10.5), results in a cell 
autonomous loss of VMH neuronal subtype identity. Remarkably, we also detect a non-
cell autonomous expansion and reprogramming of neighboring wild type cells, which 
likely occurs in response to residual Shh ligand that was not taken up by Smo mutant 
cells. This gain in Shh signaling activity may explain the pathogenesis of hypothalamic 
hamartomas (HH), a benign tumor caused, in some cases, by somatic gene mutations 
that block Shh responsiveness (Saitsu et al. 2016; Hildebrand et al., 2016). 
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Results 
Shh is required for the development of tuberal hypothalamic nuclei 
To determine how Shh signaling contributes to the formation of tuberal 
hypothalamic nuclei we first evaluated the expression of cell type specific markers in 
SBE2-cre; Shhloxp/- (Shh∆hyp) embryos. SBE2-cre is a transgenic mouse line that uses 
Shh brain enhancer 2 (SBE2) to activate cre transcription in the ventral diencephalon in 
a similar pattern to the endogenous expression of Shh. We previously showed that Shh 
is selectively deleted in the ventral diencephalon of Shh∆hyp embryos by E9.0 (Zhao et 
al., 2012). The expression of cell type specific markers of the DMH (Hmx3), VMH 
(Nr5a1) and ARC (Pro-opiomelanocortin, POMC; Tyrosine Hydoxylase, TH; and 
Somatostatin, Sst) nuclei was either absent or greatly diminished in Shh∆hyp embryos at 
E14.5 (Fig. 9A-K; POMC: control 140.8 ± 52.9, Shh∆hyp 1.0 ± 1.7, n=5, p=0.0004; TH: 
control 104.0 ± 13.2, Shh∆hyp 12.3 ± 6.6, n=4, p<0.0001; Sst: control 63.0 ± 3.0, Shh∆hyp 
0.3 ± 0.6, n=3, p<0.0001). Ectopic expression of Hmx3 was also detected in the VMH, 
possibly due to its derepression in the absence of Shh (Fig. 9A, B). These results are 
consistent with previous findings demonstrating a requirement for Shh in the 
development of tuberal hypothalamic nuclei (Fig. 9L-N; Szabó et al., 2009; Shimogori et 
al., 2010; Carreno et al., 2017). 
Alterations in dorsoventral patterning, neurogenesis and ventral midline formation 
explain the absence of tuberal hypothalamic nuclei in Shh∆hyp embryos 
Shh signaling is required to establish distinct neuronal identities at ventral 
positions along the length of the vertebrate neural tube through the activation and 
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repression of homeodomain and basic helix-loop-helix (bHLH) transcription factors 
(Ericson et al., 1997; Briscoe et al., 1999; Briscoe et al., 2000; Muhr et al., 2001; 
Balaskas et al., 2012). However, the temporal and spatial dynamics of Shh signaling in 
the hypothalamus differ from more posterior regions of the CNS. Shh is initially broadly 
expressed in ventral hypothalamic progenitors and then rapidly downregulated in the 
ventral midline at the level of the tuberal hypothalamus (Manning et al., 2006; Trowe et 
al., 2013). Consequently, Shh is expressed in bilateral stripes adjacent to the ventral 
midline, unlike spinal cord and hindbrain regions where Shh is restricted to the floor plate 
(Fig. 10A; and Echelard et al., 1993). Moreover, neural progenitors immediately dorsal to 
the bilateral stripes of Shh are responsive to Shh signaling, indicated by Gli1 expression, 
whereas progenitors located in the ventral midline are refractory to Shh signaling (Fig. 
10B; and Ohyama et al., 2008). 
We evaluated key patterning genes in Shh∆hyp mutants at E10.5 to address 
whether alterations in their expression might explain the loss of tuberal hypothalamic 
nuclei at later stages. As expected, Shh and Gli1 were absent in Shh∆hyp embryos (Fig. 
10A,B,H,I). The number of cells expressing Nkx2.1, a broad determinant of ventral 
hypothalamic progenitor identity (Kimura et al., 1996; Sussel et al., 1999), was reduced 
by 48% in Shh∆hyp embryos compared to control littermates (Fig. 10C,J,O; control: 540.8 
± 56.4, n=5; Shh∆hyp: 282.0 ± 22.0, n=6, p<0.0001). In addition, Pax6, a prethalamic 
marker was expanded ventrally to a position abutting the Nkx2.1 domain (Fig. 10C,J). 
Nkx2.2 is expressed in Shh responsive progenitors of the DMH that occupy the gap 
between Pax6 and Nkx2.1 (Fig. 10D). The expression of Nkx2.2 was dramatically 
reduced in Shh∆hyp embryos (Fig. 10D,K,P; control: 221.0 ± 21.2, n=4; Shh∆hyp: 1.6 ± 2.1, 
n=5, p<0.0001), which may explain the ventral expansion of Pax6 due to deficient cross-
51 
 
repressive interactions between these transcription factors (Ericson et al., 1997; Briscoe 
et al., 1999; Muhr et al., 2001). These results suggest that alterations in the dorsoventral 
patterning of tuberal hypothalamic progenitors are responsible, at least in part, for the 
loss of their identities in Shh∆hyp embryos. 
The bHLH transcription factor, Ascl1, is required for ARC and VMH neurogenesis 
(McNay et al., 2006). We observed an 81% reduction in the number of Ascl1 expressing 
cells in the ventral hypothalamus of Shh∆hyp embryos compared to control littermates 
(Fig. 10E,L,Q; control: 252.7 ± 11.7, n=3; Shh∆hyp: 47.0 ± 18.5, n=3, p<0.0001). 
Therefore, the reduction of neuroendocrine neurons in the ARC and VMH nuclei of 
Shh∆hyp embryos may also be explained by the downregulation of Ascl1. 
Another striking feature of Shh∆hyp embryos is the dysmorphic appearance of the 
ventral midline. Rather than the V-shaped morphology typical of wild type embryos, the 
ventral midline of Shh∆hyp embryos is U-shaped with a flattened appearance (Fig. 
10F,M). Ventral midline cells in the tuberal hypothalamus undergo BMP dependent cell-
cycle arrest and express the T-box protein, Tbx3 (Manning et al., 2006; Trowe et al., 
2013). We quantified the zone of non-proliferation by counting the number of DAPI 
positive nuclei in the Ki67 negative ventral midline territory and observed a significant 
increase in Shh∆hyp embryos (Fig. 10F,M,R; 50.5 ± 3.7, n=4) compared to control 
littermates (14.67 ± 1.5, n=3, p<0.0001). The length of the ventral midline territory 
marked by Tbx3 was also significantly increased in Shh∆hyp embryos (Fig. 10G,N,S; 
239.1 ± 8.2 µm, n=3) compared to control littermates (96.7 ± 11.6 µm, n=3, p=0.0001). 
These results demonstrate that the loss of Shh in the tuberal hypothalamus expands the 
fate of non-dividing ventral midline cells at the expense of proliferating Nkx2.1 positive 
neural progenitors. Interestingly, Bmp4 was previously shown to be upregulated in the 
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ventral midline of Shh∆hyp embryos (Zhao et al., 2012). Hence, our findings highlight a 
unique role for Shh in restricting the size of the ventral midline in the tuberal 
hypothalamus by opposing Bmp signaling, in stark contrast to the floor plate promoting 
activity of Shh in more posterior regions of the CNS (Echelard et al., 1993; Roelink et al., 
1994; Roelink et al., 1995; Marti et al., 1995; Ericson et al., 1996; Chiang et al., 1996). 
Descendants of Shh expressing progenitors contribute to the VMH 
Shh and Gli1 continue to be expressed beyond the stage when tuberal 
hypothalamic progenitors first acquire their identity and extend into the peak period of 
DMH, VMH and ARC neurogenesis between E12.5 and E14.5 (Fig. 11). We next sought 
to determine the relative contributions of Shh expressing and Shh responsive 
progenitors to distinct tuberal hypothalamic nuclei. We used a genetic fate mapping 
strategy to indelibly label Shh expressing (ShhCreER) and Shh responsive (Gli1CreER) 
progenitors with an inducible GFP reporter (RosaZsGreen). Pregnant dams carrying either 
ShhCreER/+; RosaZsGreen/+ or Gli1CreER/+; RosaZsGreen/+ embryos were administered tamoxifen 
at E10.5. The contribution of Shh and Gli1 expressing cells to tuberal hypothalamic 
nuclei was evaluated by co-labeling with GFP and cell type specific markers at E14.5.  
The majority of postmitotic neurons in the VMH express Nr5a1 and Nkx2.1 at 
E14.5 (Fig. 12A,B; Correa et al., 2015). GFP+ cells in ShhCreER/+; RosaZsGreen/+ embryos 
were detected in the ventricular zone adjacent to the VMH as well as 46% of Nr5a1 
positive neurons (Fig. 12A,G). This finding suggests that Shh expressing progenitors in 
the ventricular zone of the tuberal hypothalamus migrate radially to populate the VMH, in 
agreement with a previous study (Alvarez-Bolado et al., 2012). GFP and Nr5a1 double 
labeled neurons were enriched in ventral (199.3 ± 11.9, n=3) compared to dorsal (112.3 
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± 8.0, n=3, p=0.0005) regions of the VMH in ShhCreER/+; RosaZsGreen/+ embryos (Figs. 12A 
and 13). A similar ventral VMH bias was observed for GFP and Nkx2.1 double labeled 
neurons (Fig. 12B). Nkx2.2 is expressed in a subset of post-mitotic neurons in the dorsal 
VMH, of which 22% co-label with GFP (Fig. 12C,G). These data reveal that descendants 
of Shh expressing progenitors marked with GFP at E10.5 are partitioned along the 
dorsoventral axis of the VMH into primarily ventral and central positions and are largely 
excluded from the dorsal most region (Figs. 12J and 13). 
We also assessed the contribution of Shh expressing progenitors to other tuberal 
hypothalamic nuclei. The DMH is composed of GABA-ergic neurons that express Gad1 
and a subset of neurons that express Isl1. No overlap in GFP and Gad1 or Isl1 was 
observed in the DMH of ShhCreER/+; RosaZsGreen/+ embryos, suggesting that Shh 
expressing progenitors do not contribute to this nucleus when labeled at E10.5 (Fig. 
12H-J). Some overlap between GFP and Isl1 was observed in ventrolateral neurons in 
the VMH, as well as a small subset of ARC neurons (Fig. 12I,N). In summary, Shh 
expressing neuronal progenitors in the tuberal hypothalamus predominantly contribute to 
the VMH when labeled at E10.5. 
Descendants of Gli1 expressing progenitors contribute to the DMH and VMH 
We next examined the fate of Shh responsive cells in Gli1CreER/+; 
RosaZsGreen/+embryos administered tamoxifen at E10.5 and collected at E14.5. Given that 
Gli1 is expressed dorsal to Shh, we expected that GFP+ cells would be confined to the 
DMH. Indeed, GFP+ cells were detected in the ventricular zone immediately adjacent to 
the DMH, as well as in Gad1 and Isl1 expressing neurons that appeared to migrate 
radially into the DMH (Fig. 12K-N). 
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Surprisingly, we also identified a small population of Nr5a1 neurons in the VMH 
of Gli1CreER/+; RosaZsGreen/+ embryos that co-labeled with GFP (Fig. 12D,G; 10.6% ± 1.4%, 
n=3). These GFP+ cells appeared to stream ventrally from a more dorsal progenitor 
domain to occupy a dorsolateral region of the VMH (Fig. 12D-F). GFP and Nr5a1 double 
labeled neurons were enriched in dorsal (57.3 ± 13.5, n=3) compared to ventral (5.0 ± 
1.7, n=3, p=0.002) regions of the VMH in Gli1CreER/+; RosaZsGreen/+ embryos (Figs. 12D 
and 13). GFP co-labeling was also observed with Nkx2.1 and Nkx2.2 in primarily dorsal 
regions of the VMH (Fig. 12E-G). These data suggest that VMH neurons originate from 
spatially segregated pools of Shh expressing and Shh responsive progenitors that may 
contribute to the cellular heterogeneity of the VMH (Fig. 12J,M). 
Shh signaling is required to maintain tuberal hypothalamic progenitors in a 
proliferative state 
         The results of our lineage tracing and gene expression experiments 
demonstrated that Shh signaling is active in tuberal hypothalamic progenitors after their 
dorsoventral identity is established. To address whether Shh signaling is also required at 
later stages of DMH and VMH neurogenesis we generated mice in which Smoothened 
(Smo), an essential regulator of Shh signaling, was conditionally deleted in Gli1 
expressing cells after E10.5. 
Pregnant dams carrying Gli1CreER/+; Smoloxp/-; RosaZsGreen/+ (cSmo) and Gli1CreER/+; 
Smoloxp/+; RosaZsGreen/+ (control) embryos were administered tamoxifen at E10.5 and 
collected at different developmental stages. Strikingly, the number of GFP positive cells 
in the tuberal hypothalamus was decreased by 43% in cSmo embryos (453.8 ± 52.27, 
n=8) compared to control littermates (800.2 ± 155.3, n=9, p=0.0003) when harvested at 
55 
 
E14.5 (Fig. 14A-C). This reduction in GFP+ cells was detected in both mantle and 
ventricular zones. A significant reduction in the number of GFP+ cells was also observed 
one day earlier at E13.5 (Fig. 14D-F; cSmo: 418.1 ± 45.5, n=7, versus control: 603 ± 
138.9, n=6, p=0.0066), but not at E12.5 (Fig.14 G-I; cSmo: 512.4 ± 96.1, n=5, versus 
control: 578.6 ± 96.7, n=5, p>0.05). 
         The failed expansion of Shh responsive cells in cSmo embryos between E12.5 
and E14.5 might be explained by increased cell death, decreased proliferation, or both. 
Immunostaining for activated caspase-3, an indicator of apoptosis, was minimal in cSmo 
and control embryos at E14.5 with no significant differences between genotypes (Fig. 
15). On the other hand, fewer GFP positive cells co-labeled with the proliferation marker 
Ki67 in the ventricular zone of cSmo embryos at E12.5 (Fig. 14J-L; 28.5% ± 6.2%, n=3) 
compared to control littermates (50.1% ± 8.7%, n=9, p=0.0249). From these results, we 
conclude that Shh signaling is required to maintain tuberal hypothalamic progenitors in a 
mitotically active state during the peak period of VMH and DMH neurogenesis. 
Cell-autonomous requirement for Smo in promoting tuberal hypothalamic neuron 
identity 
Given the contribution of Shh responsive cells to distinct neuronal subtypes in the 
DMH and VMH, we next assessed whether aspects of their identity were compromised 
in cSmo mutants. We observed a 30% reduction in the number of Isl1 positive neurons 
in the DMH of cSmo (Fig. 16A-C; 477.6 ± 130.7, n=5) compared to control littermates 
(678.3 ± 44.6, n=4, p=0.0229). There was also a 30% reduction in the number of 
neurons expressing Nkx2.2 in the dorsal VMH of cSmo (Fig. 16D-F; 315.2 ± 52.1, n=9) 
compared to control embryos (451.6 ± 28.2, n=9; p<0.0001). These findings, in 
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conjunction with the proliferation defects described above, suggest that the conditional 
loss of Shh signaling after E10.5 causes a cell autonomous reduction of distinct DMH 
and VMH neuronal subtypes. 
  
Non-cell autonomous defects in cSmo embryos alter VMH neuron subtype identity 
Remarkably, despite the reduction of Nkx2.2 staining in cSmo embryos, the total 
number of Nr5a1 expressing neurons in the VMH was unchanged (Fig. 16G-I; cSmo: 
598.5 ± 100.7, n=8, versus control: 590.8 ± 196.4, n=6, p=0.9253). Moreover, fewer 
Nr5a1 expressing neurons co-labeled with Nkx2.1 in cSmo embryos, which was 
especially notable in ventral regions of the VMH where Gli1 is not normally expressed 
(Fig. 16J-L). The presence of defects in regions of the tuberal hypothalamus that are not 
known to be Shh responsive suggests that some of the phenotypes in cSmo embryos 
may occur through non-cell autonomous mechanisms. 
The seemingly incongruous findings that Nkx2.2 neurons are partially reduced in 
the dorsal VMH of cSmo embryos without an effect on the total number of VMH cells 
prompted us to reassess the specification of tuberal hypothalamic progenitors. Nkx2.1 
marks a broad ventral region of the ventricular zone in control embryos at E14.5, from 
the ventral midline of the hypothalamus to a dorsal limit that approximates the border 
between the VMH and DMH (Fig. 17A). The expression of Nkx2.2 overlaps with Nkx2.1 
at the level of the dorsal VMH and extends dorsally into the ventricular zone of the 
prethalamus (Fig. 17A). There was a significant reduction in the number of cells 
expressing Nkx2.1 in the ventricular zone of cSmo embryos (Fig. 17A; cSmo: 131.0 ± 
80.4, n=5, versus control: 259.4 ± 58.9, n=5, p=0.0205) and a concomitant ventral 
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expansion of Nkx2.2 (Fig. 17A; cSmo: 118.2 ± 42.9, n=9, versus control: 58.0 ± 23.2, 
n=9, p=0.002). Given that Nkx2.2 is a direct transcriptional target of Shh signaling, it was 
puzzling that its expression was increased in cSmo mutants (Lei et al., 2006; Vokes et 
al., 2007). We evaluated other molecular readouts of Shh signaling and observed a 
similar ventral expansion of Olig2 (cSmo: 125.8 ± 12.9, n=5, versus control: 73.4 ± 6.5, 
n=5, p<0.0001) and Ki67 (cSmo: 107.0 ± 13.5, n=8, versus control: 81.8 ± 16.4, n=9, 
p=0.0037) in cSmo embryos (Fig. 17B,C). Notably, the cells displaying ectopic 
expression of Nkx2.2, Olig2 and Ki67 were not GFP positive, suggesting that they were 
wild type cells that had not undergone Smo recombination (Fig. 18). No change in the 
expression of Gli1 was observed between cSmo and control embryos at E14.5, 
suggesting that the ectopic response to Shh signaling was transient and/or occurred at 
an earlier stage (Fig. 17D). The most parsimonious explanation for these results is that 
the conditional deletion of Smo prevented the normal uptake of Shh ligand, causing a 
non-cell autonomous gain in Shh signaling in neighboring wild type cells (Fig. 17E). 
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 Discussion 
Previous studies identified requirements for Shh at distinct spatial and temporal 
points in hypothalamic development, from induction to nucleogenesis (Chiang et al., 
1996; Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012). Here, we further 
define the phenotypic consequences and pathogenic mechanisms attributed to the loss 
of Shh signaling at early (E9.0) and late (after E10.5) stages of hypothalamic 
development. We determine that the loss of hypothalamic nuclei in cases where Shh 
was deleted at early time points results from requirements for Shh in establishing proper 
dorsoventral patterning, neurogenesis, and limiting the expansion of the non-proliferative 
ventral midline. Using an inducible approach, we then characterize requirements for later 
Shh activity, at time points after dorsoventral patterning has been established. We find 
that Shh is necessary to maintain proliferation and subtype identity of VMH and DMH 
progenitors during peak periods of hypothalamic neurogenesis. 
Shh directs dorsoventral patterning and neurogenesis in the hypothalamus 
Our results confirm that the early source of Shh in the hypothalamus is required 
to generate the full complement of tuberal hypothalamic neurons (Szabó et al., 2009; 
Shimogori et al., 2010; Zhao et al., 2012). In order to understand the mechanism 
underlying the loss of these cell types in ShhΔhyp mutants, we evaluated embryos at 
E10.5 and observed a failure to activate the appropriate patterning, proliferation and 
neurogenic programs. This result is consistent with the known morphogenetic role of 
Shh in establishing ventral neuronal identities through the regulation of homeodomain 
and bHLH transcription factors with some notable differences described below (Ericson 
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et al., 1997; Briscoe et al., 1999; Briscoe et al., 2000; Muhr et al., 2001; Balaskas et al., 
2012). 
At spinal cord and hindbrain levels of the CNS, the notochord is the principle 
source of Shh required to specify ventral neuronal progenitors, whereas, the secondary 
source of Shh in the floor plate is needed for the formation of later born glial and 
ependymal cells types (Matise et al., 1998; Yu et al., 2013). In contrast to the notochord, 
the expression of Shh in the prechordal plate is transient and only present for sufficient 
time to specify the hypothalamic territory, marked by Nkx2.1, but not the identity of 
neuronal progenitors (Szabó et al., 2009). Instead, it is the hypothalamic source of Shh 
that establishes VMH and DMH progenitor domains. Thus, whereas notochord derived 
Shh activates target genes, such as Nkx2.2 and Olig2, in the overlying neural tube, a 
similar function is fulfilled by the hypothalamic source of Shh. Given that hypothalamic 
neurons develop over a protracted period compared to most spinal cord neurons, it 
makes sense that they rely on an enduring source of Shh within the hypothalamus for 
their development (Davis et al., 2004; Altman and Bayer, 2006; Ishii and Bouret, 2012). 
Shh restricts ventral midline development in the tuberal hypothalamus 
In addition to the dorsoventral patterning and neurogenic defects, our analysis of 
Shh∆hyp mutants revealed an unexpected expansion of ventral midline identity. It is likely 
that the increased number of ventral midline cells in Shh∆hyp embryos is a consequence 
of heightened Bmp signaling as evidenced by the expanded zone of non-proliferation 
and Tbx3 expression, two molecular readouts of this pathway (Manning et al., 2006). 
Indeed, the loss of Shh signaling in the anterior hypothalamus of Shh∆hyp embryos was 
previously shown to cause a rostral shift in Bmp4 expression as early as E9.5 (Zhao, et 
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al., 2012). Interestingly, a similar phenotype was also observed in Lrp2-/- mutant 
embryos, including a downregulation in Shh signaling, flattened and expanded ventral 
midline, and a rostral shift in Bmp4 expression (Christ et al., 2012). Lrp2 belongs to the 
LDL receptor gene family and binds both Shh (as a co-receptor) and Bmp4 (as a 
scavenger receptor) (McCarthy et al., 2002; Spoelgen et al., 2005; Christ et al., 2012). 
Therefore, a disruption in the balance of Shh and Bmp signaling, loss and gain 
respectively, is responsible for the ventral midline defects in Lrp2-/- and ShhΔhyp mutants. 
A role for Shh in restricting ventral midline development in the tuberal 
hypothalamus is intriguing given the opposite function it plays in promoting floor plate 
induction in posterior regions of the CNS (Echelard et al., 1993; Roelink et al., 1995; 
Martí et al., 1995; Ericson et al., 1996; Chiang et al., 1996). Why might Shh have 
contrasting roles in the development of ventral midline cells at different levels of the 
neural tube? Firstly, the cells at the ventral midline of the tuberal hypothalamus, known 
as the median eminence, differ from floor plate cells in the spinal cord in that they are 
comprised of tanycytes, a specialized form of radial glia with neurogenic and gliogenic 
properties (Rizzoti and Lovell-Badge, 2017). In mammals, floor plate cells of the spinal 
cord are considered glial-like but do not give rise to neurons or glia. Tanycytes are an 
integral component of the hypophyseal portal system that connects the hypothalamus to 
the pituitary gland and regulate a variety of homeostatic processes given their access to 
blood borne signals (Rodríguez et al., 2005; Robins et al., 2013; Bolborea and Dale, 
2013). Secondly, the hypothalamic ventral midline is a site of integration for multiple 
signaling pathways, including Shh, Bmp, Wnt and Fgf that help facilitate the unique 
organization of the hypothalamic-pituitary axis (Manning et al., 2006; Davis and 
Camper., 2007; Zhu et al., 2007; Potok et al., 2008; Zhao et al., 2012; Carreno et al., 
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2017; Fu et al., 2017). At the level of the spinal cord, Shh is the primary regulator of 
ventral neuronal identities, with additional signals serving to modulate Shh 
responsiveness (Gouti et al., 2015; Kong et al., 2015). Thirdly, Shh expressing cells in 
the hypothalamus are different from elsewhere in the neural tube in that they constitute 
actively dividing neuronal progenitors (Szabó et al., 2009; this study). Within the spinal 
cord, Shh expressing floor plate cells lack neurogenic properties. Given the clear 
differences in ventral development between the hypothalamus and spinal cord, it is not 
altogether surprising that Shh exhibits unique and overlapping functions at each of these 
CNS regions. 
Later Shh signaling- delineating fates 
We sought to investigate roles and requirements for the enduring source of Shh 
in the tuberal hypothalamus. Our lineage tracing experiments revealed biased 
contributions of Shh expressing and Shh responding lineages to the VMH and DMH. On 
the basis of this observation, we wondered whether integration of progenitors may serve 
as a potential means by which neuronal heterogeneity is achieved within these 
hypothalamic nuclei. 
Shh expressing and Shh responsive populations mix to give rise to the large 
domain of Nr5a1 cells in the VMH, though their contributions remain somewhat spatially 
discrete. Initially found broadly in the VMH, Nr5a1 expression becomes restricted to the 
VMHDM by P0 (Cheung et al., 2013; Correa et al., 2015). Transcriptome analysis of the 
VMH in both neonatal and adult mice has revealed enrichment of 200 genes relative to 
expression in neighboring nuclei (Segal et al., 2005; Kurrasch et al., 2007). Examining 
the patterns of these markers revealed distinct spatial domains and biases, some 
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overlapping with Nr5a1 and some mutually exclusive. Thus, it is clear that VMH neurons 
are diverse in nature. Molecular characterization of VMH neuronal subclasses has 
largely been performed in postnatal animals. Specifically, Islet1 and ERα are restricted 
to the VMHVL (Davis et al., 2004), BDNF to the VMHDM and VMHC (McClellan et al., 
2006), and leptin receptor to the VMHDM (Balthasar et al., 2004; Dhillon et al., 2006). 
However, little is known regarding the processes through which these diverse 
populations are specified. Thus, within the VMH, the ventral bias of cells derived from 
Shh expressing progenitors and the dorsal bias of Gli1 expressing descendants may be 
indicative of a role for Shh signaling as a means of delineating distinct fates within a 
single nucleus. 
The migration of a small number of Shh responsive progenitors into the VMH 
bears similarity to other hypothalamic cell types that originate from outside of their local 
progenitor territory. Most neuronal populations in the ARC are generated from 
multipotent progenitors that migrate radially from the adjacent ventricular zone (Li et al., 
1996; McNay et al., 2006; Yee et al., 2009; Pelling et al., 2011; Lu et al., 2013; Lee et 
al., 2016), however some cells migrate tangentially from distal locations. For instance, 
GnRH neurons originate in the olfactory bulb and cross substantial distance to arrive at 
their final location within the ARC (Wray et al., 1989; Wray, 2002). Moreover, gene 
expression studies suggest that some Sst neurons migrate to the ARC from an anterior 
hypothalamic birthplace (Morales-Delgado et al., 2011). We propose that the migration 
of a Shh responsive cell population into the VMH, albeit from a nearby location, may 
further explain how cellular diversity is achieved in this nucleus. 
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Later Shh signaling- maintaining proliferation of progenitor pools 
In assessing the requirements of Shh at later stages of hypothalamic 
development, we observed a dependency on Shh for maintaining tuberal hypothalamic 
progenitors in a mitotically active state. When Shh signaling was disrupted after E10.5, 
there were fewer cSmo mutant cells in the VMH and DMH due to reduced cell division. 
Thus, Shh signaling is required to maintain hypothalamic progenitors in a mitotically 
active state during peak periods of VMH and DMH neurogenesis. These results are 
consistent with previous findings demonstrating a mitogenic role for Shh in other 
neurodevelopmental contexts (Rowitch et al.,1999; Wallace, 1999; Wechsler-Reya and 
Scott, 1999; Fuccillo et al., 2006; Komada et al., 2008). 
Non-cell autonomous phenotypes in cSmo mutants due to heightened Shh 
signaling 
Our analysis of cSmo embryos also revealed that Shh is required to maintain the 
subtype identity of postmitotic VMH neurons. Despite the reduced number of Nkx2.2+, 
GFP+ neurons in the dorsal VMH of cSmo embryos, the total number of VMH neurons 
was unchanged. Moreover, fewer VMH neurons expressed Nkx2.1, especially in ventral 
regions where Smo was not deleted. We propose a non-cell autonomous mechanism to 
account for some of these differences in VMH neuron identity, whereby residual Shh 
ligand that was not taken up by cSmo mutant cells signaled to adjacent wild type 
progenitors, altering their patterns of gene expression and proliferation. In further 
support of this claim, a similar non-cell autonomous upregulation of Shh signaling was 
previously described upon the mosaic deletion of Smo in the ventral telencephalon (Xu 
et al., 2010). 
64 
 
Our observation of increased Shh signaling in non-recombined cells from cSmo 
mutant embryos is provocative in light of the association of somatic mutations in 
regulators of Shh signaling with hypothalamic hamartomas (Craig et al., 2008; Wallace 
et al., 2008; Hildebrand et al., 2016; Saitsu et al., 2016). Hypothalamic hamartomas are 
benign tumors that form during fetal brain development and, depending on their size and 
location, may disrupt endocrine function and cause seizures. Dominant mutations in 
GLI3 that produce a truncated protein with constitutive repressor activity were identified 
in hypothalamic hamartomas (Craig et al., 2008; Wallace et al., 2008; Hildebrand et al., 
2016; Saitsu et al., 2016). Individuals with Pallister Hall syndrome possess similar 
germline truncating mutations in GLI3 and also develop hypothalamic hamartomas 
(Kang et al., 1997). Mutations in other components of the SHH signaling pathway, OFD1 
and PRKRAC (encoding the catalytic subunit ɑ of PKA), have also been described in 
resected hamartoma tissue (Hildebrand et al., 2016; Saitsu et al., 2016). 
The mechanism of hypothalamic hamartoma formation is unknown. 
Paradoxically, the mutations that have been described in SHH pathway components are 
generally thought to inhibit SHH signaling, which, given its mitogenic activity, would be 
expected to suppress rather than promote the growth of this ectopic mass. Interestingly, 
the allele rate for somatic mutations in GLI3 and OFD1 ranged from 7-54%, suggesting 
that in some instances only a fraction of the cells in a given hypothalamic hamartoma 
may actually contain mutations (Saitsu et al., 2016). As with the cSmo mutants 
described in our study, somatic mosaicism in hypothalamic hamartomas may provide 
wild type cells with a temporary boost in SHH signaling and transient growth advantage, 
due to reduced ligand uptake by mutant cells that have lost their responsiveness to 
SHH. While experiments in our study did not extend into postnatal life and may not have 
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targeted enough cells to induce hypothalamic hamartomas, they do nevertheless offer a 
compelling explanation for how these ectopic growths might form during brain 
development. 
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Materials and Methods 
Mice 
All animal work was approved by the Institutional Animal Care and Use Committee 
(IACUC) at the Perelman School of Medicine, University of Pennsylvania. The SBE2-cre 
mouse line was previously described (Zhao, et al., 2012). Gli1CreER (Gli1tm3(cre/ERT2)Alj), 
Gli1lacZ (Gli1 tm2Alj), RosaZsGreen (Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze), Shh+/−, Shhloxp/loxp 
(Shhtm2Amc), ShhCreER (Shh tm2(cre/ERT2)Cjt), Smo+/- (Smotm1Amc), and Smoloxp/loxp (Smotm2Amc) 
mouse strains were procured from the Jackson labs (Bar Harbor, ME). Tamoxifen 
dissolved in corn oil was orally gavaged at 0.15 mg/g body weight to pregnant dams at 
appropriate developmental time points. 
 
Tissue dissection 
Embryos were collected at the stated developmental age, with noon of plug day 
designated E0.5. Heads were dissected in cold PBS and fixed in 4% paraformaldehyde 
(PFA) for 90 minutes to overnight at 4°C. Heads were then cryoprotected in 30% 
sucrose and embedded in Tissue-Tek OCT Compound. Frozen tissue was 
cryosectioned at 16 µm (for E12.5 and E13.5 embryos), 18 µm (for E14.5 embryos), or 
20 µm (for E10.5 and E18.5 embryos). 
 
Immunohistochemistry and section in situ hybridization 
Immunohistochemistry was performed with the following antibodies: mouse anti-Ascl1 
(1:100 BD Pharmingen, 556604), mouse anti-Gad1 (1:500, EMD Millipore, MAB5406), 
mouse anti-Isl1 (1:100, Developmental Studies Hybridoma Bank, 39.4D5), rabbit anti-
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Ki67 (1:1000, Novocastra. NCL-Ki67p), rabbit anti-Nkx2.1 (1:1000, Abcam, AB76013), 
mouse anti-Nkx2.2 (1:1000, DSHB, 74.5A5), rabbit anti-Olig2 (1:500, Millipore, AB9610), 
mouse anti-Pax6 (1:1000, Developmental Studies Hybridoma Bank, Pax6), rabbit anti-
POMC (1:500, Phoenix Pharmaceuticals Inc., H-029-30), mouse anti- Nr5a1 (1:200, 
R&D Systems, PP-N1665), rat anti-Somatostatin (1:200, Millipore, MAB354) rabbit anti-
Tyrosine Hydroxlase (1:1000, Pel-Freez, P40101-0). Somatostatin, Pax6, Nkx2.2, 
Nr5a1, Gad1, and Isl1 antibodies required antigen retrieval in 10mM citric acid buffer pH 
6.0 at 90° C. Mouse on Mouse detection kit (Vector Laboratories BMK-2202) was used 
for blocking and primary antibody dilution of Nkx2.2, Gad1, and Isl1 antibodies. 
Detection of primary antibodies was achieved using secondary antibodies conjugated to 
Cy3 anti-rabbit (1:200, 111-165-003, Jackson ImmunoResearch Laboratories), Cy3 anti-
mouse (1:200, 115-166-006, Jackson ImmunoResearch Laboratories), Cy3 anti-rat 
(1:200, 112-166-003, Jackson ImmunoResearch Laboratories) or AlexaFluor 633 anti- 
rabbit (1:100, Invitrogen, A21070). 
         Section in situ hybridization with digoxygenin-UTP-labeled riboprobes was 
performed as described (Nissim et al., 2007). A minimum of three each of control and 
mutant embryos were evaluated for each antibody or in situ probe. 
 
β-galactosidase staining 
Heads from Gli1lacZ/+ embryos were dissected in cold PBS and fixed in 4% 
paraformaldehyde (PFA) for 90 minutes at 4°C. Heads were then cryoprotected in 30% 
sucrose and embedded in Tissue-Tek OCT Compound. Frozen tissue was 
cryosectioned at 20 µm. Slides were then stained in a solution containing 1 mg/ml X-gal 
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at 37°C overnight. Following staining, slides were post-fixed in 4% PFA and washed in 
PBS. 
 
Quantification and statistical analysis 
All cell counts were performed using the cell counter function in ImageJ (NIH) on tissue 
sections from at least three control and mutant embryos. In cases where double labeling 
was examined for GFP and another cell specific marker, the tissue was imaged at a 
single Z-plane. Each channel (green for GFP, red for the marker) was first examined 
independently, assigning a positive count for a given marker to the DAPI stained nucleus 
most closely associated with the staining. A cell was only counted as double labeled if a 
single nucleus marked by DAPI had been assigned to the cell labeled by GFP and the 
cell specific marker. Statistical analysis of all cell counts was performed in GraphPad 
Prism using the Student’s t-test. 
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Chapter 3 Figures 
 
Figure 9. Loss of tuberal hypothalamic neurons in ShhΔhyp embryos.  
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Coronal sections through the tuberal hypothalamus of control and ShhΔhyp embryos 
stained by RNA in situ hybridization (A-D) or immunofluorescence (E-J) at E14.5 for 
neuronal markers. (A,B) Hmx3 is expressed in the DMH of control embryos, and shows 
reduced (bracket) and ectopic (asterisk) expression in ShhΔhyp mutants (n=3). (C,D) 
Nr5a1 marks the VMH in control embryos and is absent in ShhΔhyp mutants (n=4). (E-K) 
Markers of distinct neuronal subtypes in the ARC (POMC, TH, and Sst) are reduced or 
absent in ShhΔhyp mutants (n=5 for POMC, **p=0.0004; n=4 for TH, ***p<0.0001; n= 3 for 
Sst, ***p<0.0001). (L,M) Schematic of coronal sections through the tuberal 
hypothalamus of control and ShhΔhyp embryos showing nuclei and cell type specific 
markers. (N) Sagittal view of brain showing plane of section (red line) in (L-M). Scale 
bars: 100 µm. Error bars indicate S.D. Statistical analysis was performed using a two-
tailed unpaired t-test. 
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Figure 10. Altered dorsoventral patterning, neurogenesis, and ventral midline 
development in ShhΔhyp embryos.  
Coronal sections through control and ShhΔhyp embryos stained by RNA in situ 
hybridization (A,B,G-I,N) or immunofluorescence (C-F,J-M) at E10.5. (A,H) Shh 
expression in the prospective tuberal hypothalamus is lost in ShhΔhyp mutants (n=3). (B,I) 
Gli1 expression in neuronal progenitors immediately dorsal to Shh is absent in ShhΔhyp 
mutants (n=3). (C,J,O) Ventral hypothalamic expression of Nkx2.1 is reduced in ShhΔhyp 
mutants (n=5 for controls, n=6 for ShhΔhyp), whereas Pax6 is expanded ventrally. Note 
the gap between Nkx2.1 and Pax6 (white bracket) in control embryos is missing in 
ShhΔhyp mutants. (D,K,P) Nkx2.2 expression in Shh responsive tuberal hypothalamic 
progenitors is greatly reduced in ShhΔhyp mutants (n=4 for controls, n=5 for ShhΔhyp). 
(E,L,Q) Ascl1 expression in neurogenic progenitors is reduced in ShhΔhyp mutants (n=3). 
(F,M,R) The number of non-proliferating ventral midline cells identified by the absence of 
Ki67 staining is expanded in ShhΔhyp mutants (n=4). (G,N,S) The expression of Tbx3 in 
the ventral midline is expanded in ShhΔhyp mutants (n=3).  Scale bars: 100 µm. Error 
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bars indicate S.D. Statistical analysis was performed using a two-tailed unpaired t-test 
(**p<0.0001). 
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Figure 11. Persistence of Shh signaling during peak periods of hypothalamic 
neurogenesis.  
Coronal sections through the hypothalamus of (A) wild type and (B) Gli1lacZ/+ embryos at 
E12.5. (A) RNA in situ hybridization detects Shh expression along the rostrocaudal axis 
of the hypothalamus. Weak Shh expression is detected in the ventral midline at preoptic 
and anterior hypothalamic regions. Shh expression is maintained in hypothalamic 
progenitors adjacent to the ventral midline in tuberal and mammillary regions. Shh is 
also observed in the zona limitans intrathalamica (red arrowhead) in the caudal 
diencephalon. (B) X-gal staining of Gli1lacZ embryos along the rostrocaudal axis of the 
hypothalamus. X-gal staining is detected adjacent to Shh expressing domains 
throughout the hypothalamus. At the level of the tuberal hypothalamus, X-gal staining 
marks progenitors of the DMH and a population of cells that stream ventrally towards the 
VMH (arrows). Scale bars: 200 µm. 
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Figure 12. Shh and Gli1 expressing cells contribute to overlapping and distinct 
tuberal hypothalamic nuclei.  
Coronal sections through the tuberal hypothalamus of ShhCreER/+; RosaZsGreen/+ (A-C,H, I) 
and Gli1CreER/+; RosaZsGreen/+ (D-F,K,L) embryos at E14.5 that received tamoxifen at 
E10.5. The fate of Shh and Gli1 expressing cells was determined by co-labeling with 
GFP (ZsGreen) and cell type specific markers of the VMH and DMH. Insets in (A-F) are 
higher magnification views of boxed regions showing single and double labeled cells. 
(G,N) Quantification of fate-mapping experiments displayed as the proportion of double 
positive cells (from either Shh or Gli1 lineages) to the total number of cells expressing a 
given marker: Nr5a1(***p<0.0001, n=3); Nkx2.2 (*p=0.038, n=4 for Shh lineage, n=3 for 
Gli1 lineage); Nkx2.1 (***p<0.0001, n=3); Isl1 (**p<0.0003, n=3). (J,M) Schematic 
demonstrating contribution of Shh and Gli1 expressing cell lineages to tuberal 
hypopthalamic nuclei. Scale bars: 100 µm. Inset scale bars: 25 µm. Error bars indicate 
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S.D. Statistical analysis was performed using a two-tailed unpaired t-test on arcsin-
transformed data. 
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Figure 13. Shh and Gli1 lineages occupy distinct regions of the VMH. 
Coronal sections through the tuberal hypothalamus of (A) ShhCreER/+; RosaZsGreen/+ and 
(B) Gli1CreER/+; RosaZsGreen/+ embryos at E18.5 that received tamoxifen at E10.5. GFP 
(ZsGreen) fluorescence is shown on sections counterstained with DAPI. (A) Cells that 
expressed Shh at E10.5, contribute to the ventral and central regions of the VMH at 
E18.5. (B) Cells that expressed Gli1 at E10.5, contribute to the DMH and dorsal region 
of the VMH at E18.5. Scale bar: 100 µm. White dashed lines outline tuberal 
hypothalamic nuclei. 
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Figure 14. Shh signaling is required for proliferation of tuberal hypothalamic 
progenitors. 
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 Coronal sections through the tuberal hypothalamus of control and cSmo embryos at 
E14.5 (A,B), E13.5 (D,E), and E12.5 (G,H,J,K) that received tamoxifen at E10.5. (A-H) 
GFP (ZsGreen) fluorescence is shown on sections counterstained with DAPI. (C,F,I) 
Quantification of GFP positive cells from cSmo and control embryos tracked by litter. (J-
K) Co-labeling of GFP and Ki67 expressing cells (arrowhead) in the ventricular zone 
reveals less proliferation in cSmo embryos at E12.5, as quantified in (L). Scale bars: (A-
H) 100 µm (J-K) 25 µm. For all graphs, horizontal dotted line represents the mean and 
error bars indicate S.D. Each data point represents a single embryo that is color-coded 
by litter. Statistical analysis was performed using a two-tailed unpaired t-test 
(***p=0.0003, **p=0.0066, *p=0.0249). 
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Figure 15. No differences in cell death between control and cSmo embryos.  
Coronal sections of control and cSmo embryos at E14.5 that received tamoxifen at 
E10.5. Immunostaining for activated caspase-3 counterstained with DAPI reveals no 
differences in apoptosis between control and cSmo embryos (control n=5, 4.4 ± 1.3; 
cSmo n=4, 3.5 ± 1.3; p>0.05). Each data point represents a single embryo color-coded 
by litter. Scale bars:100 µm. Statistical analysis was performed using a two-tailed 
unpaired t-test. 
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Figure 16. Shh signaling is required for subtype identity of VMH and DMH 
neurons.  
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Coronal sections through the tuberal hypothalamus of control and cSmo embryos at 
E14.5 that received tamoxifen at E10.5. (A-C) The number of cells expressing Isl1 in the 
DMH is reduced in cSmo embryos (control n=4, cSmo n= 5, *p=0.0229). (D-F) The 
number of post mitotic neurons expressing Nkx2.2 in the dorsal VMH is reduced in cSmo 
embryos compared to control littermates (n=9, **p<0.0001). (G-I) The number of VMH 
neurons expressing Nr5a1 is equivalent between control and cSmo embryos (control 
n=6, cSmo n= 8, ns p>0.05). (J-L) The number of post-mitotic neurons expressing 
Nkx2.1 in the tuberal hypothalamus is reduced in cSmo embryos (n=5, *p=0.0174). For 
all graphs, horizontal dotted line represents the mean and error bars indicate S.D. Each 
data point represents a single embryo that is color-coded by litter. Statistical analysis 
was performed using a two-tailed unpaired t-test. 
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Figure 17. Non-cell autonomous alterations in hypothalamic progenitors in cSmo 
embryos.  
Coronal sections through the tuberal hypothalamus of control and cSmo embryos at 
E14.5 (tamoxifen administered at E10.5). (A) The boundary between Nkx2.1 and Nk2.2 
expressing progenitors (yellow bracket) is shifted ventrally in the ventricular zone of 
cSmo embryos compared to control littermates. The ventral expansion of Nkx2.2 
expressing progenitors (n=9, **p=0.002) is concomitant with a reduction in the number of 
cells expressing Nkx2.1 (n=5, *p=0.0205). (B) Olig2 is ectopically expressed in ventral 
tuberal hypothalamic progenitors in cSmo embryos compared to control littermates (n=5, 
***p<0.0001). (C) Ki67 is ectopically expressed in ventral tuberal hypothalamic 
progenitors in cSmo embryos compared to control littermates (control n=9, cSmo n=8, 
**p=0.0037). (D) Gli1 expression is unchanged between control and cSmo embryos 
(n=3). (E) Schematic model depicting the non-cell autonomous gain in Shh 
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responsiveness by ventral tuberal hypothalamic progenitors in cSmo mutant embryos 
compared to control littermates. For all graphs, horizontal dotted line represents the 
mean and error bars indicate S.D. Each data point represents a single embryo that is 
color-coded by litter. Statistical analysis was performed using a two-tailed unpaired t-
test. Scale bars: 50 µm. 
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Figure 18. cSmo embryos show ectopic activation of Shh responsive genes in 
non-recombined (wild type) cells.  
Coronal sections through the tuberal hypothalamus of control and cSmo embryos at 
E14.5 (tamoxifen administered at E10.5). Shh responsive progenitors in control embryos 
frequently co-label with GFP and Nkx2.2, Olig2, or Ki67 (open arrowhead). The majority 
of progenitors in cSmo embryos showing ectopic expression of Nkx2.2, Olig2, or Ki67 do 
not co-label with GFP (closed arrowheads), suggesting that they derive from non-
recombined (wild type) cells. (A,B) The ventral boundary of Nkx2.2 and Olig2 expression 
(white dotted bracket) is shifted ventrally in cSmo embryos. The same images are shown 
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in Figure 6 without the GFP overlay. For all graphs, horizontal dotted line represents the 
mean and error bars indicate S.D. Each data point represents a single embryo that is 
color-coded by litter. Statistical analysis was performed using a two-tailed unpaired t-test 
(**p=0.0003, ***p<0.0001). Scale bar: 50 µm. 
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CHAPTER 4: Conclusions and Future Directions 
 
One of the foremost questions in the field of developmental biology is how the 
limited molecular toolkit encoded in the genome is used iteratively to give rise to 
complex structures composed of heterogenous cell types. The hypothalamus has been 
extensively studied for that very reason. Though it is derived from the neural tube in the 
same manner as other structures of the central nervous system, the hypothalamus 
requires precise temporal regulation of Shh expression and signaling domains for proper 
development.  
 
Distinct roles for Shh in the hypothalamus: 
Previous studies have identified requirements for Shh at distinct spatial and 
temporal points in hypothalamic development, from early induction to nucleogenesis 
(Chiang et al., 1996; Szabó et al., 2009; Shimogori et al., 2010; Zhao et al., 2012). In 
addition to providing an atlas of hypothalamic gene expression, Shimogori and 
colleagues also hinted at requirements for the hypothalamic source of Shh. Using an 
Nkx2.1-Cre line to delete Shh, they found a profound disruption of hypothalamic nuclei 
and loss of gene expression along the rostrocaudal axis (Shimogori et al., 2010). 
However, this work was descriptive in nature and any mechanism underlying the loss of 
hypothalamic populations was not suggested. Further studies of roles for Shh and its 
corresponding signaling activity in the hypothalamus soon followed. In 2012, Alvarez-
Bolado and colleagues further described the dynamic pattern of Shh expression in the 
developing hypothalamus (Alvarez-Bolado, et al., 2012). Using genetic inducible fate 
mapping techniques driven by the ShhCreER mouse line, they uncovered the contribution 
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of Shh expressing cells and their progeny to the hypothalamic territories. They found 
cells expressing Shh before E9.5 give rise to neurons and astrocytes populating the 
preoptic, tuberal, and mammillary hypothalamus. Later induction time points, in contrast, 
resulted in progressively smaller contributions to the preoptic and mammillary 
hypothalamus. The tuberal hypothalamus saw a steady contribution of Shh-expressing 
cells at the level of the VMH during the remainder of neurogenesis (Alvarez-Bolado, et 
al., 2012). Previous work from our lab described a requirement for early Shh in 
establishing proper patterning of the hypothalamus along the anteroposterior axis and 
for proper placement and specification of the pituitary (Zhao, et al., 2012).  
The work presented in the preceding chapters serves to further characterize the 
phenotypic consequences and pathogenic mechanisms attributed to the loss of Shh 
signaling at early (E9.0) and late (after E10.5) stages of hypothalamic development. We 
determine that the loss of hypothalamic nuclei in cases where Shh is deleted at early 
time points results from additional requirements for Shh in establishing proper 
dorsoventral patterning, neurogenesis, and limiting the expansion of the non-proliferative 
ventral midline. Using an inducible and conditional approach, we then characterize 
requirements for later Shh activity, at time points after dorsoventral patterning has been 
established. We find that Shh is necessary to maintain proliferation and subtype identity 
of VMH and DMH progenitors during peak periods of hypothalamic neurogenesis. Later, 
Shh acts as a mitogen to ensure proper proliferation and expansion of progenitors to 
give rise to the full complement of tuberal hypothalamic neurons. 
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Shh-expressing cells in the hypothalmus are unique: 
Our analysis of Shh∆hyp mutants revealed an unexpected phenotype within the 
ventral midline of the hypothalamus. In Shh∆hyp mutants, we observed an expansion of 
midline identity. This potential role for Shh in restricting ventral midline development in 
the tuberal hypothalamus is intriguing given the function associated with Shh in more 
posterior regions of the CNS where Shh promotes floor plate identity in the (Echelard et 
al., 1993; Roelink et al., 1995; Martí et al., 1995; Ericson et al., 1996; Chiang et al., 
1996).  We hypothesized that this distinct role of Shh in limiting the ventral midline may 
be in part due to the different nature of midline cells at this level. At more posterior levels 
of the central nervous system in mammals, floor plate cells of the spinal cord are 
considered glial-like but do not give rise to neurons or glia. However, the specialized 
tanycyte glial cells in the hypothalamic midline connects the hypothalamus to the 
pituitary gland and regulate a variety of homeostatic processes given their access to 
blood borne signals (Rodríguez et al., 2005; Robins et al., 2013; Bolborea and Dale, 
2013). Additionally, the fact that the hypothalamic ventral midline is a site of integration 
for multiple signaling pathways, including Shh, Bmp, Wnt and Fgf may explain a different 
role for Shh in the midline cells at this level (Gouti et al., 2015; Kong et al., 2015).  
Perhaps the most striking difference of the hypothalamus is that the Shh 
expressing cells in the hypothalamus are different from elsewhere in the neural tube in 
that they constitute actively dividing neuronal progenitors (Szabó et al., 2009). Within the 
spinal cord, Shh expressing floor plate cells lack neurogenic properties. Further 
highlighting this unique feature of neurogenic progenitors expressing Shh is that in the 
neurogenic midline of the midbrain, progenitors must extinguish Shh expression (Bayly 
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et al., 2007; Joksimovic et al., 2009; Joksimovic et al., 2009b; Perez-Balaguer et al., 
2009).  
Heterogeneity of hypothalamic neurons: 
The developmental mechanisms regulating the vast neuronal heterogeneity 
within the hypothalamus remains poorly understood compared to other regions of the 
central nervous system (Bedont et al., 2015; Burbridge et al., 2016; Xie and Dorsky, 
2017). In fact, the extent of that heterogeneity is still being realized. In a seminal paper, 
Shimogori and colleagues used high throughput techniques to catalog gene expression 
of the developing hypothalamus (Shimogori, et al., 2010). Hypothalamic tissue was 
collected from brains at each day of development beginning in mid-gestation (E10.5) as 
well as early postnatal and adult stages. Microarray experiments on this panel of tissue 
highlighted subsets of genes expressed during development as well as those that 
became markers of mature neuron populations. Further, these authors went on to 
perform large-scale in situ hybridization analysis to describe the general and/or region-
specific expression patterns of transcription factors and neuropeptides at different time 
points of hypothalamic development. The advent of single-cell techniques including 
Drop-Seq have also proved useful in further characterizing the diversity of cell types in 
the tuberal hypothalamus (Campbell et al., 2017). 
The work presented in Chapter 3 of this work serves to uncover some of the 
factors that may act along the differentiation pathways of subpopulations within the 
VMH. Of note we find the dorsomedial VMH population of neurons which are marked by 
post-mitotitc expression of Nkx2.2 are likely derived from a Shh-responsive population. 
Gene expression analysis of adult hypothalamic issue suggests these dorsomedial VMH 
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neurons include a leptin receptor expressing population implicated in mediating effects 
on body weight (Dhillon et al., 2006; Kurrasch et al., 2007) However, this population of 
Nkx2.2 expressing cells has been minimally described in the literature. Additional 
experiments are necessary to identify requirements for Shh signaling within these 
compartments as well as other factors that may further define them. 
Furthermore, experiments beyond the scope of the work presented here could 
address the lineage of adult neuronal populations in the tuberal hypothalamus. As fate 
mapping experiments using the Gli1CreER and ShhCreER mouse lines were carried out as 
late as E18.5, we have yet to track the fate of these lineages in the adult hypothalamus. 
The expression of numerous markers of mature hypothalamic cell types and active 
neurons are difficult to assess at embryonic time points. Thus, carrying these 
experiments into early and later postnatal life would allow for the examination of a larger 
set of gene expression markers. 
Mosaic nature of Hh deletion: 
The experiments presented in Chapter 3 made use of inducible and conditional 
approaches to attenuate Hh signaling in mice. These approaches targeted the obligate 
transducer of the Hh pathway, Smo in a Hh-signaling dependent manner. Thus, our 
approach allowed for the disruption of further Hh signaling only in those cells which were 
already Hh responsive. Ideally, additional experiments would be performed using 
complementary approach in which the ligand of the pathway is deleted. However, 
because we took this experimental approach, we were able to take advantage of the 
mosaic nature of conditional Smo deletion. This allowed for the unique opportunity to 
91 
 
observe both recombined and non-recombined cells within the context of a single 
animal.  
In fact, we observed hyperproliferation of non-recombined cells in a tamoxifen-
treated animal. Furthermore, we saw increased Nkx2.2 and Olig2 expression in the 
ventricular zone of cSmo animals. This is of interest for two reasons. First, Nkx2.2 is a 
direct transcriptional target of Shh signaling while Olig2 is known to be induced following 
high levels of Shh signaling. Second, the cells which ectopically expressed Nkx2.2 and 
Olig2 were largel, negative for our marker of recombination (ZsGreen). This is indicative 
of wild type cells experiencing higher levels of Shh signaling in cSmo mutant embryos.  
It is possible that the lack of ligand uptake by cSmo cells allows for inappropriate 
spreading of ligand to cells that would normally not respond to Shh. This is not the first 
example of a mosaic deletion of Smo resulting in ectopic activation of the Shh signaling 
pathway in normally non-responsive cells. In one such example, neighbors of MGE cells 
which have been made refractory to Shh signaling through Six3-Cre mediated deletion 
of Smo exhibited surprising upregulation of Shh pathway targets and compensated for a 
loss of mutant-derived somatostatin expressing neurons (Xu et al., 2010). An additional 
explanation for the ectopic Hh signaling observed in cSmo animals is that targeted cells 
may fail to properly express secreted inhibitors of the Shh signaling pathway. At present, 
we can not rule out the possibility that cSmo cells may fail to express secreted inhibitors 
that would normally limit signaling. In this  
As stated in Chapter 3, the observed phenotype of our cSmo mice which may 
display an increase of Shh signaling output in non-recombined cells was reminiscent of a 
human condition in which patients harbor mutations in regulators of the Hedgehog 
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pathway. In sporadic cases of Pallister Hall Syndrome with hypothalamic hamartomas 
(HH), truncating mutations in or loss of heterozygosity at the genomic region surrounding 
Gli3 are often seen as the causative genetic factors. Known mutations cluster near the 
DNA-binding and transactivation domains of Gli3 to produce a truncated protein, which 
acts as a constitutive repressor of Hh signaling (Craig et al., 2008; Démurger et al., 
2015; Saitsu et al., 2016). Mutations in additional negative regulators of the Hh signaling 
pathway, OFD1 and PRKRAC (encoding the catalytic subunit ɑ of PKA), have also been 
described in resected HH tissue (Hildebrand et al., 2016; Saitsu et al., 2016).  
One of the prevailing models in the study of HH is that neighboring cells not 
harboring the mutations are exposed to higher levels of Shh signaling due to a lack of 
ligand uptake. While the experiments within the scope of our study did not extend into 
postnatal life and may not have targeted enough cells sufficient to induce HH, the 
similarity of non-cell autonomous phenotypes observed here in cases of mosaic 
recombination of Smo and those present in HH is intriguing. Though HH can be 
comprised of predominantly neurons or glia, our observation of ectopic Olig2 expression 
in cSmo mutants may indicate bias towards giving rise to a glial HH (Coons et al., 2007). 
Previous attempts to establish mouse models of HH have not been fruitful. Future study 
using this particular genetic model may prove useful as a mouse model of HH. 
 
 
 
 
 
93 
 
BIBLIOGRAPHY 
Ahlgren S. C., Thakur V. and Bronner-Fraser M. (2002). Sonic hedgehog rescues 
cranial neural crest from cell death induced by ethanol exposure. Proc. Natl. Acad. Sci. 
USA 99, 10476-10481. 
 
Allen, B.L., Tenzen, T., and McMahon, A.P. (2007). The Hedgehog-binding proteins 
Gas1 and Cdo cooperate to positively regulate Shh signaling during mouse 
development. Genes Dev. 21, 1244–1257.  
Allen B. L., Song J. Y., Izzi L., Althaus I. W., Kang J.-S., Charron F., Krauss R. S. 
and McMahon A. P. (2011). Overlapping roles and collective requirement for the 
coreceptors GAS1, CDO, and BOC in SHH pathway function. Dev. Cell 20, 775-787.  
 
Altman, J. and Bayer, S. A. (1986). The development of the rat hypothalamus. Adv 
Anat Embryol Cell Biol 100, 1–178. 
 
Alvarez-Bolado, G., Paul, F. A. and Blaess, S. (2012). Sonic hedgehog lineage in the 
mouse hypothalamus: from progenitor domains to hypothalamic regions. Neural Dev 7, 
4. 
 
Aoto K., Shikata Y., Higashiyama D., Shiota K. and Motoyama J. (2008). Fetal 
ethanol exposure activates protein kinase A and impairs Shh expression in prechordal 
mesendoderm cells in the pathogenesis of holoprosencephaly. Birth Defects Res. A Clin. 
Mol. Teratol. 82, 224-231. 
 
Ashwell K. W. S. and Zhang L.-L. (1994). Optic nerve hypoplasia in an acute exposure 
model of the fetal alcohol syndrome. Neurotoxicol. Teratol. 16, 161-167.  
 
Balaskas, N., Ribeiro, A., Panovska, J., Dessaud, E., Sasai, N., Page, K. M., 
Briscoe, J. and Ribes, V. (2012). Gene regulatory logic for reading the Sonic Hedgehog 
signaling gradient in the vertebrate neural tube. Cell 148, 273–284. 
 
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., 
McGovern, R. A., Chua, S. C., Elmquist, J. K., et al. (2004). Leptin receptor signaling 
in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983–991. 
 
Bedont, J. L., Newman, E. A. and Blackshaw, S. (2015). Patterning, specification, and 
differentiation in the developing hypothalamus. Wiley Interdiscip Rev Dev Biol 4, 445– 
468. 
 
Blader P. and Strähle U. (1998). Ethanol impairs migration of the prechordal plate in 
the zebrafish embryo. Dev. Biol. 201, 185-201. 
 
Bolborea, M. and Dale, N. (2013). Hypothalamic tanycytes: potential roles in the control 
of feeding and energy balance. Trends in Neurosciences 36, 91–100. 
 
94 
 
Briscoe, J. and Ericson, J. (1999). The specification of neuronal identity by graded 
Sonic Hedgehog signalling. Semin Cell Dev Biol 10, 353–62. 
Briscoe, J., Pierani, A., Jessell, T. M. and Ericson, J. (2000). A homeodomain protein 
code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 
101, 435–445. 
 
Briscoe, J. and Ericson, J. (2001). Specification of neuronal fates in the ventral neural 
tube. Curr. Opin. Neurobiol. 11, 43–49. 
 
Brzezinski J. A. IV, Prasov L. and Glaser T. (2012). Math5 defines the ganglion cell 
competence state in a subpopulation of retinal progenitor cells exiting the cell cycle. Dev. 
Biol. 365, 395-413.  
 
Büdefeld, T., Tobet, S. A. and Majdic, G. (2011). Altered position of cell bodies and 
fibers in the ventromedial region in SF-1 knockout mice. Experimental Neurology 232, 
176–184. 
 
Bumcrot, D.A., Takada, R., and McMahon, A.P. (1995). Proteolytic processing yields 
two secreted forms of sonic hedgehog. Mol. Cell. Biol. 15, 2294–2303. 
 
Burbridge, S., Stewart, I. and Placzek, M. (2016). Development of the Neuroendocrine 
Hypothalamus. Compr Physiol 6, 623–643. 
 
Campbell, J. N., Macosko, E. Z., Fenselau, H., Pers, T. H., Lyubetskaya, A., Tenen, 
D., Goldman, M., Verstegen, A. M. J., Resch, J. M., McCarroll, S. A., et al. (2017). A 
molecular census of arcuate hypothalamus and median eminence cell types. Nature 
Neuroscience 20, 484. 
 
Caqueret, A., Boucher, F. and Michaud, J. L. (2006). Laminar organization of the early 
developing anterior hypothalamus. Dev. Biol. 298, 95–106. 
 
Cardozo M. J., Sánchez-Arrones L., Sandonis A., Sánchez-Camacho C., Gestri G.,  
Wilson S. W., Guerrero I. and Bovolenta P. (2014). Cdon acts as a Hedgehog decoy 
receptor during proximal-distal patterning of the optic vesicle. Nat. Commun. 5, 4272  
 
Carreno, G., Apps, J. R., Lodge, E. J., Panousopoulos, L., Haston, S., Gonzalez-
Meljem, J. M., Hahn, H., Andoniadou, C. L. and Martinez-Barbera, J. P. (2017). 
Hypothalamic sonic hedgehog is required for cell specification and proliferation of 
LHX3/LHX4 pituitary embryonic precursors. Development 144, 3289–3302. 
 
Cemeroglu A. P., Coulas T. and Kleis L. (2015). Spectrum of clinical presentations 
and endocrinological findings of patients with septo-optic dysplasia: a retrospective 
study. J. Pediatr. Endocrinol. Metab. 28, 1057-1063.  
 
Cheung, C. C., Kurrasch, D. M., Liang, J. K. and Ingraham, H. A. (2013). Genetic 
labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of 
95 
 
the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a 
separate non-SF-1 neuronal cluster in the ventrolateral VMH. J. Comp. Neurol. 521, 
1268–1288. 
 
Chiang, C., Litingtung, Y., Lee, E., Young, K., Corden, J., Westphal, H. and Beachy, 
P. (1996). Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene 
function. Nature 383, 407–13. 
 
Christ, A., Christa, A., Kur, E., Lioubinski, O., Bachmann, S., Willnow, T. E. and 
Hammes, A. (2012). LRP2 is an auxiliary SHH receptor required to condition the 
forebrain ventral midline for inductive signals. Dev. Cell 22, 268–278. 
 
Cole F. and Krauss R. S. (2003). Microform holoprosencephaly in mice that lack the Ig 
superfamily member Cdon. Curr. Biol. 13, 411-415.  
 
Correa, S. M., Newstrom, D. W., Warne, J. P., Flandin, P., Cheung, C. C., Lin-Moore, 
A. T., Pierce, A. A., Xu, A. W., Rubenstein, J. L. and Ingraham, H. A. (2015). An 
Estrogen-Responsive Module in the Ventromedial Hypothalamus Selectively Drives Sex-
Specific Activity in Females. Cell Reports 10, 62–74. 
 
Coulter C. L., Leech R. W., Schaefer G. B., Scheithauer B. W. and Brumback R. A. 
(1993). Midline cerebral dysgenesis, dysfunction of the hypothalamic-pituitary axis, and 
fetal alcohol effects. Arch. Neurol. 50, 771-775.  
 
Craig, D. W., Itty, A., Panganiban, C., Szelinger, S., Kruer, M. C., Sekar, A., Reiman, 
D., Narayanan, V., Stephan, D. A. and Kerrigan, J. F. (2008). Identification of somatic 
chromosomal abnormalities in hypothalamic hamartoma tissue at the GLI3 locus. Am. J. 
Hum. Genet. 82, 366–374. 
 
Dale, J. K., Vesque, C., Lints, T. J., Sampath, T. K., Furley, A., Dodd, J. and 
Placzek, M. (1997). Cooperation of BMP7 and SHH in the induction of forebrain ventral 
midline cells by prechordal mesoderm. Cell 90, 257–269. 
 
Dakubo G. D., Wang Y. P., Mazerolle C., Campsall K., McMahon A. P. and Wallace 
V. A. (2003). Retinal ganglion cell-derived sonic hedgehog signaling is required for optic 
disc and stalk neuroepithelial cell development. Development 130, 2967-2980.  
 
Davis, A. M., Seney, M. L., Stallings, N. R., Zhao, L., Parker, K. L. and Tobet, S. A. 
(2004). Loss of steroidogenic factor 1 alters cellular topography in the mouse 
ventromedial nucleus of the hypothalamus. J. Neurobiol. 60, 424–436. 
 
Davis, S. W. and Camper, S. A. (2007). Noggin regulates Bmp4 activity during pituitary 
induction. Dev. Biol. 305, 145–160. 
 
Deiner M. S., Kennedy T. E., Fazeli A., Serafini T., Tessier-Lavigne M. and Sretavan 
D. W. (1997). Netrin-1 and DCC mediate axon guidance locally at the optic disc: loss of 
function leads to optic nerve hypoplasia. Neuron 19, 575-589.  
96 
 
Dhillon, H., Zigman, J. M., Ye, C., Lee, C. E., McGovern, R. A., Tang, V., Kenny, C. 
D., Christiansen, L. M., White, R. D., Edelstein, E. A., et al. (2006). Leptin directly 
activates SF1 neurons in the VMH, and this action by leptin is required for normal body-
weight homeostasis. Neuron 49, 191–203. 
 
Downing C., Balderrama-Durbin C., Broncucia H., Gilliam D. and Johnson T. E. 
(2009). Ethanol teratogenesis in five inbred strains of mice. Alcohol. Clin. Exp. Res. 33, 
1238-1245. 
 
Echelard, Y., Epstein, D. J., St-Jacques, B., Shen, L., Mohler, J., McMahon, J. A. 
and McMahon, A. P. (1993). Sonic hedgehog, a member of a family of putative 
signaling molecules, is implicated in the regulation of CNS polarity. Cell 75, 1417–1430. 
 
Ericson, J., Morton, S., Kawakami, A., Roelink, H. and Jessell, T. M. (1996). Two 
critical periods of Sonic Hedgehog signaling required for the specification of motor 
neuron identity. Cell 87, 661–673. 
 
Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van 
Heyningen, V., Jessell, T. M. and Briscoe, J. (1997). Pax6 controls progenitor cell 
identity and neuronal fate in response to graded Shh signaling. Cell 90, 169–180. 
 
Feng L., Xie Z. H., Ding Q., Xie X., Libby R. T. and Gan L. (2010). MATH5 controls the 
acquisition of multiple retinal cell fates. Mol. Brain 3, 36.  
 
Fu, T., Towers, M. and Placzek, M. A. (2017). Fgf10+ progenitors give rise to the chick 
hypothalamus by rostral and caudal growth and differentiation. Development 144, 3278–
3288. 
 
Fuccillo, M., Joyner, A. L. and Fishell, G. (2006). Morphogen to mitogen: the multiple 
roles of hedgehog signalling in vertebrate neural development. Nat. Rev. Neurosci. 7, 
772–783. 
 
Garcia-Filion P. and Borchert M. (2013). Prenatal determinants of optic nerve 
hypoplasia: review of suggested correlates and future focus. Surv. Ophthalmol. 58, 610-
619.  
 
Gaston-Massuet C., McCabe M. J., Scagliotti V., Young R. M., Carreno G., Gregory 
L. C., Jayakody S. A., Pozzi S., Gualtieri A., Basu B. et al. (2016). Transcription factor 
7-like 1 is involved in hypothalamo–pituitary axis development in mice and humans. 
Proc. Natl. Acad. Sci. USA 113, E548-E557 
 
Gilbert M. T., Sulik K. K., Fish E. W., Baker L. K., Dehart D. B. and Parnell S. E. 
(2016). Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice. 
Neurotoxicol. Teratol. 58:15-2. 
 
Godin E. A., O'Leary-Moore S. K., Khan A. A., Parnell S. E., Ament J. J., Dehart D. 
B., Johnson B. W., Allan Johnson G., Styner M. A. and Sulik K. K. (2010). Magnetic 
97 
 
resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: 
effects of acute insult on gestational day 7. Alcohol. Clin. Exp. Res. 34, 98-111.  
Goodrich, L.V., Milenković, L., Higgins, K.M., and Scott, M.P. (1997). Altered neural 
cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113. 
Gouti, M., Metzis, V. and Briscoe, J. (2015). The route to spinal cord cell types: a tale 
of signals and switches. Trends Genet. 31, 282–289. 
 
Gregory L. C., Gaston-Massuet C., Andoniadou C. L., Carreno G., Webb E. A., 
Kelberman D., McCabe M. J., Panagiotakopoulos L., Saldanha J. W., Spoudeas H. 
A. et al. (2015). The role of the sonic hedgehog signalling pathway in patients with 
midline defects and congenital hypopituitarism. Clin. Endocrinol. (Oxf.) 82, 728-738. 
 
Haddad N. G. and Eugster E. A. (2005). Hypopituitarism and neurodevelopmental 
abnormalities in relation to central nervous system structural defects in children with 
optic nerve hypoplasia. J. Pediatr. Endocrinol. Metab. 18, 853-858.  
 
Hashikawa, Y., Hashikawa, K., Falkner, A. L. and Lin, D. (2017). Ventromedial 
Hypothalamus and the Generation of Aggression. Front Syst Neurosci 11. 
Hellström A. (1999). Optic nerve morphology may reveal adverse events during 
prenatal and perinatal life—digital image analysis. Surv. Ophthalmol. 44 Suppl. 1, S63-
S73.  
 
Higashiyama D., Saitsu H., Komada M., Takigawa T., Ishibashi M. and Shiota K. 
(2007). Sequential developmental changes in holoprosencephalic mouse embryos 
exposed to ethanol during the gastrulation period. Birth Defects Res. A Clin. Mol. 
Teratol. 79, 513-523. 
 
Hildebrand, M. S., Griffin, N. G., Damiano, J. A., Cops, E. J., Burgess, R., Ozturk, 
E., Jones, N. C., Leventer, R. J., Freeman, J. L., Harvey, A. S., et al. (2016). 
Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with 
Gelastic Epilepsy. Am. J. Hum. Genet. 99, 423–429. 
 
Hong M. and Krauss R. S. (2012). Cdon mutation and fetal ethanol exposure synergize 
to produce midline signaling defects and holoprosencephaly spectrum disorders in mice. 
PLoS Genet. 8, e1002999 
 
Hong M. and Krauss R. S. (2013). Rescue of holoprosencephaly in fetal alcohol- 
exposed Cdon mutant mice by reduced gene dosage of Ptch1. PLoS ONE 8, e79269 
 
Hui, C.C., Slusarski, D., Platt, K.A., Holmgren, R., and Joyner, A.L. (1994). 
Expression of three mouse homologs of the Drosophila segment polarity gene cubitus 
interruptus, Gli, Gli-2, and Gli-3, in ectoderm- and mesoderm-derived tissues suggests 
multiple roles during postimplantation development. Dev. Biol. 162, 402–413.  
Ingham, P. W. and McMahon, A. P. (2001). Hedgehog signaling in animal 
development: paradigms and principles. Genes Dev. 15, 3059–3087. 
98 
 
Ishii, Y. and Bouret, S. G. (2012). Embryonic birthdate of hypothalamic leptin-activated 
neurons in mice. Endocrinology 153, 3657–3667. 
 
Ikeda, Y., Luo, X., Abbud, R., Nilson, J. H. and Parker, K. L. (1995). The nuclear 
receptor steroidogenic factor 1 is essential for the formation of the ventromedial 
hypothalamic nucleus. Mol. Endocrinol. 9, 478–486. 
 
Jessell, T. M. (2000). Neuronal specification in the spinal cord: inductive signals and 
transcriptional codes. Nature Reviews Genetics 1, 20–29. 
 
Kang, S., Graham, J.M. Jr, Olney, A.H. and Biesecker, L.G. (1997). GLI3 frameshift 
mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet. 15, 266-8. 
 
Khaliullina H., Bilgin M., Sampaio J. L., Shevchenko A. and Eaton S. (2015). 
Endocannabinoids are conserved inhibitors of the Hedgehog pathway. Proc. Natl. Acad. 
Sci. USA 112, 3415-3420. 
 
Kietzman H. W., Everson J. L., Sulik K. K. and Lipinski R. J. (2014). The teratogenic 
effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 
haploinsufficiency in the mouse. PLoS ONE 9, e89448 
 
Kim, K. W., Li, S., Zhao, H., Peng, B., Tobet, S. A., Elmquist, J. K., Parker, K. L. and 
Zhao, L. (2010). CNS-specific ablation of steroidogenic factor 1 results in impaired 
female reproductive function. Mol. Endocrinol. 24, 1240–1250. 
Kimura, S., Hara, Y., Pineau, T., Fernandez-Salguero, P., Fox, C. H., Ward, J. M. and 
Gonzalez, F. J. (1996). The T/ebp null mouse: thyroid-specific enhancer-binding protein 
is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. 
Genes Dev. 10, 60–69. 
 
Kinzler, K.W., Ruppert, J.M., Bigner, S.H., and Vogelstein, B. (1988). The GLI gene 
is a member of the Kruppel family of zinc finger proteins. Nature 332, 371–374.  
Kleiber M. L., Diehl E. J., Laufer B. I., Mantha K., Chokroborty-Hoque A., Alberry B. 
and Singh S. M. (2014). Long-term genomic and epigenomic dysregulation as a 
consequence of prenatal alcohol exposure: a model for fetal alcohol spectrum disorders. 
Front. Genet. 5, 161. 
 
Klöckener, T., Hess, S., Belgardt, B. F., Paeger, L., Verhagen, L. A. W., Husch, A., 
Sohn, J.-W., Hampel, B., Dhillon, H., Zigman, J. M., et al. (2011). High-fat feeding 
promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons. 
Nat. Neurosci. 14, 911–918. 
 
Kolpak A., Zhang J. and Bao Z.-Z. (2005). Sonic hedgehog has a dual effect on the 
growth of retinal ganglion axons depending on its concentration. J. Neurosci. 25, 3432-
3441. 
 
Komada, M., Saitsu, H., Kinboshi, M., Miura, T., Shiota, K. and Ishibashi, M. (2008).  
99 
 
Hedgehog signaling is involved in development of the neocortex. Development 135, 
2717–2727. 
 
Kong, J. H., Yang, L., Dessaud, E., Chuang, K., Moore, D. M., Rohatgi, R., Briscoe, 
J. and Novitch, B. G. (2015). Notch activity modulates the responsiveness of neural 
progenitors to sonic hedgehog signaling. Dev. Cell 33, 373–387. 
 
Kunwar, P. S., Zelikowsky, M., Remedios, R., Cai, H., Yilmaz, M., Meister, M. and 
Anderson, D. J. (2015). Ventromedial hypothalamic neurons control a defensive 
emotion state. Elife 4,. 
 
Kurrasch, D., Cheung, C., Lee, F., Tran, P., Hata, K. and Ingraham, H. (2007). The 
Neonatal Ventromedial Hypothalamus Transcriptome Reveals Novel Markers with 
Spatially Distinct Patterning. Journal of Neuroscience 27, 13624–13634. 
 
Lee, H., Kim, D.-W., Remedios, R., Anthony, T. E., Chang, A., Madisen, L., Zeng, H. 
and Anderson, D. J. (2014). Scalable control of mounting and attack by Esr1+ neurons 
in the ventromedial hypothalamus. Nature 509, 627–632. 
 
Lee, B., Lee, S., Lee, S.-K. and Lee, J. W. (2016). The LIM-homeobox transcription 
factor Isl1 plays crucial roles in the development of multiple arcuate nucleus neurons. 
Development 143, 3763–3773. 
 
Lei, Q., Jeong, Y., Misra, K., Li, S., Zelman, A.K., Epstein, D.J. and Matise, M.P. 
(2006). Wnt signaling inhibitors regulate the transcriptional response to morphogenetic 
Shh–Gli signaling in the neural tube. Dev. Cell 11, 325–337. 
Li, H., Zeitler, P. S., Valerius, M. T., Small, K. and Potter, S. S. (1996). Gsh-1, an 
orphan Hox gene, is required for normal pituitary development. EMBO J. 15, 714–724. 
 
Li Y.-X., Yang H.-T., Zdanowicz M., Sicklick J. K., Qi Y., Camp T. J. and Diehl A. M. 
(2007). Fetal alcohol exposure impairs Hedgehog cholesterol modification and signaling. 
Lab. Invest. 87, 231-240. 
 
Lipinski R. J., Godin E. A., O'leary-Moore S. K., Parnell S. E. and Sulik K. K. (2010). 
Genesis of teratogen-induced holoprosencephaly in mice. Am. J. Med. Genet. C Semin. 
Med. Genet. 154C, 29-42. 
 
Lipinski R. J., Hammond P., O'Leary-Moore S. K., Ament J. J., Pecevich S. J., Jiang 
Y., Budin F., Parnell S. E., Suttie M., Godin E. A. et al. (2012). Ethanol-induced face-
brain dysmorphology patterns are correlative and exposure-stage dependent. PLoS 
ONE 7, e43067. 
 
Lin, D., Boyle, M. P., Dollar, P., Lee, H., Lein, E. S., Perona, P. and Anderson, D. J. 
(2011). Functional identification of an aggression locus in the mouse hypothalamus. 
Nature 470, 221–226. 
 
100 
 
Loucks E. J. and Ahlgren S. C. (2009). Deciphering the role of Shh signaling in axial 
defects produced by ethanol exposure. Birth Defects Res. A Clin. Mol. Teratol. 85, 556-
567. 
 
Lu, F., Kar, D., Gruenig, N., Zhang, Z. W., Cousins, N., Rodgers, H. M., Swindell, E. 
C., Jamrich, M., Schuurmans, C., Mathers, P. H., et al. (2013). Rax is a selector gene 
for mediobasal hypothalamic cell types. J. Neurosci. 33, 259–272. 
 
Majdic, G., Young, M., Gomez-Sanchez, E., Anderson, P., Szczepaniak, L. S., 
Dobbins, R. L., McGarry, J. D. and Parker, K. L. (2002). Knockout Mice Lacking 
Steroidogenic Factor 1 Are a Novel Genetic Model of Hypothalamic Obesity. 
Endocrinology 143, 607–614. 
 
Manning, L., Ohyama, K., Saeger, B., Hatano, O., Wilson, S. A., Logan, M. and 
Placzek, M. (2006). Regional Morphogenesis in the Hypothalamus: A BMP-Tbx2 
Pathway Coordinates Fate and Proliferation through Shh Downregulation. 
Developmental Cell 11, 873–885. 
 
Marigo V., Johnson R. L., Vortkamp A. and Tabin C. J. (1996). Sonic hedgehog 
differentially regulates expression of GLI and GLI3 during limb development. Dev. Biol. 
180, 273-283. 
 
Martí, E., Bumcrot, D. A., Takada, R. and McMahon, A. P. (1995). Requirement of 
19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. 
Nature 375, 322–325. 
Matise, M. P., Epstein, D. J., Park, H. L., Platt, K. A. and Joyner, A. L. (1998). Gli2 is 
required for induction of floor plate and adjacent cells, but not most ventral neurons in 
the mouse central nervous system. Development 125, 2759–2770. 
 
McCabe M. J., Alatzoglou K. S. and Dattani M. T. (2011). Septo-optic dysplasia and 
other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract. 
Res. Clin. Endocrinol. Metab. 25, 115-124. 
 
McCarthy, R. A., Barth, J. L., Chintalapudi, M. R., Knaak, C. and Argraves, W. S. 
(2002). Megalin functions as an endocytic sonic hedgehog receptor. J. Biol. Chem. 277, 
25660–25667. 
 
McClellan, K., Parker, K. and Tobet, S. (2006). Development of the ventromedial 
nucleus of the hypothalamus. Frontiers in Neuroendocrinology 27, 193–209. 
 
McLellan J. S., Zheng X., Hauk G., Ghirlando R., Beachy P. A. and Leahy D. J. 
(2008). The mode of Hedgehog binding to Ihog homologues is not conserved across 
different phyla. Nature 455, 979-983. 
 
McNay, D. E. G., Pelling, M., Claxton, S., Guillemot, F. and Ang, S.-L. (2006). Mash1 
is required for generic and subtype differentiation of hypothalamic neuroendocrine cells. 
Mol. Endocrinol. 20, 1623–1632. 
101 
 
Morales-Delgado, N., Merchan, P., Bardet, S. M., Ferrán, J. L., Puelles, L. and Díaz, 
C. (2011). Topography of Somatostatin Gene Expression Relative to Molecular 
Progenitor Domains during Ontogeny of the Mouse Hypothalamus. Front Neuroanat 5. 
 
Morishima A. and Aranoff G. S. (1986). Syndrome of septo-optic-pituitary dysplasia: 
the clinical spectrum. Brain Dev. 8, 233-239. 
 
Muhr, J., Andersson, E., Persson, M., Jessell, T. M. and Ericson, J. (2001). 
Groucho-mediated transcriptional repression establishes progenitor cell pattern and 
neuronal fate in the ventral neural tube. Cell 104, 861–873. 
 
Mu X., Fu X., Beremand P. D., Thomas T. L. and Klein W. H. (2008). Gene regulation 
logic in retinal ganglion cell development: Isl1 defines a critical branch distinct from but 
overlapping with Pou4f2. Proc. Natl. Acad. Sci USA 105, 6942-7. 
 
Murray P. G., Paterson W. F. and Donaldson M. D. C. (2005). Maternal age in patients 
with septo-optic dysplasia. J. Pediatr. Endocrinol. Metab. 18, 471-476. 
 
Nissim, S., Allard, P., Bandyopadhyay, A., Harfe, B. D. and Tabin, C. J. (2007). 
Characterization of a novel ectodermal signaling center regulating Tbx2 and Shh in the 
vertebrate limb. Dev. Biol. 304, 9–21.  
 
Nüsslein-Volhard, C. and Wieschaus, E. (1980). Mutations affecting segment 
number and polarity in Drosophila. Nature 287, 795–801. 
 
Ohyama, K., Das, R. and Placzek, M. (2008). Temporal progression of hypothalamic 
patterning by a dual action of BMP. Development 135, 3325–3331. 
 
Pan L., Deng M., Xie X. and Gan L. (2008). ISL1 and BRN3B co-regulate the 
differentiation of murine retinal ganglion cells. Development 135, 1981-1990. 
 
Patel L., McNally R. J. Q., Harrison E., Lloyd I. C. and Clayton P. E. (2006).  
Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in 
Northwest England. J. Pediatr. 148, 85-88. 
 
Paulo S. S., Fernandes-Rosa F. L., Turatti W., Coeli-Lacchini F. B., Martinelli C. E. 
Jr., Nakiri G. S., Moreira A. C., Santos A. C., de Castro M. and Antonini S. R. (2015). 
Sonic Hedgehog mutations are not a common cause of congenital hypopituitarism in the 
absence of complex midline cerebral defects. Clin. Endocrinol. (Oxf). 82, 562-569. 
 
Pelling, M., Anthwal, N., McNay, D., Gradwohl, G., Leiter, A. B., Guillemot, F. and 
Ang, S.-L. (2011). Differential requirements for neurogenin 3 in the development of 
POMC and NPY neurons in the hypothalamus. Dev. Biol. 349, 406–416. 
 
102 
 
Potok, M. A., Cha, K. B., Hunt, A., Brinkmeier, M. L., Leitges, M., Kispert, A. and 
Camper, S. A. (2008). WNT signaling affects gene expression in the ventral 
diencephalon and pituitary gland growth. Dev. Dyn. 237, 1006–1020. 
 
Prasov L. and Glaser T. (2012). Dynamic expression of ganglion cell markers in retinal  
progenitors during the terminal cell cycle. Mol. Cell. Neurosci. 50, 160-168. 
 
Ribeiro I. M., Vale P. J., Tenedorio P. A., Rodrigues P. A., Bilhoto M. A. and Pereira 
H. C. (2007). Ocular manifestations in fetal alcohol syndrome. Eur. J. Ophthalmol. 17, 
104-109. 
 
Rizzoti, K. and Lovell-Badge, R. (2017). Pivotal role of median eminence tanycytes for 
hypothalamic function and neurogenesis. Molecular and Cellular Endocrinology 445, 7–
13. 
 
Robins, S. C., Stewart, I., McNay, D. E., Taylor, V., Giachino, C., Goetz, M., 
Ninkovic, J., Briancon, N., Maratos-Flier, E., Flier, J. S., et al. (2013). α-Tanycytes of 
the adult hypothalamic third ventricle include distinct populations of FGF-responsive 
neural progenitors. Nat Commun 4, 2049. 
 
Rodríguez, E. M., Blázquez, J. L., Pastor, F. E., Peláez, B., Peña, P., Peruzzo, B. and 
Amat, P. (2005). Hypothalamic tanycytes: a key component of brain-endocrine 
interaction. Int. Rev. Cytol. 247, 89–164. 
 
Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i Altaba, A., 
Tanabe, Y., Placzek, M., Edlund, T. and Jessell, T. M. (1994). Floor plate and motor 
neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the 
notochord. Cell 76, 761–775. 
 
Roelink, H., Porter, J. A., Chiang, C., Tanabe, Y., Chang, D. T., Beachy, P. A. and 
Jessell, T. M. (1995). Floor plate and motor neuron induction by different concentrations 
of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81, 445–
455. 
 
Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S. W., Tsui L.-C. and 
Muenke M. (1996). Mutations in the human Sonic Hedgehog gene cause 
holoprosencephaly. Nat. Genet. 14, 357-360. 
 
Rossi A., Kontarakis Z., Gerri C., Nolte H., Hölper S., Krüger M. and Stainier D. Y. 
R. (2015). Genetic compensation induced by deleterious mutations but not gene 
knockdowns. Nature 524, 230-233. 
 
Rowitch, D. H., S-Jacques, B., Lee, S. M., Flax, J. D., Snyder, E. Y. and McMahon, 
A. P. (1999). Sonic hedgehog regulates proliferation and inhibits differentiation of CNS 
precursor cells. J. Neurosci. 19, 8954–8965. 
 
103 
 
Saitsu, H., Sonoda, M., Higashijima, T., Shirozu, H., Masuda, H., Tohyama, J., Kato, 
M., Nakashima, M., Tsurusaki, Y., Mizuguchi, T., et al. (2016). Somatic mutations in 
GLI3 and OFD1 involved in sonic hedgehog signaling cause hypothalamic hamartoma. 
Ann Clin Transl Neurol 3, 356–365. 
 
Sakagami K., Gan L. and Yang X.-J. (2009). Distinct effects of Hedgehog signaling on 
neuronal fate specification and cell cycle progression in the embryonic mouse retina. J. 
Neurosci. 29, 6932-6944. 
 
Sanchez-Camacho C. and Bovolenta P. (2008). Autonomous and non-autonomous 
Shh signalling mediate the in vivo growth and guidance of mouse retinal ganglion cell 
axons. Development 135, 3531-3541 
 
Saper, C. B. and Lowell, B. B. (2014). The hypothalamus. Curr. Biol. 24, R1111-1116. 
Segal, J. P., Stallings, N. R., Lee, C. E., Zhao, L., Socci, N., Viale, A., Harris, T. M., 
Soares, M. B., Childs, G., Elmquist, J. K., et al. (2005). Use of Laser-Capture 
Microdissection for the Identification of Marker Genes for the Ventromedial Hypothalamic 
Nucleus. J. Neurosci. 25, 4181–4188. 
 
Shimada, M. and Nakamura, T. (1973). Time of neuron origin in mouse hypothalamic 
nuclei. Exp. Neurol. 41, 163–173. 
 
Shimogori, T., Lee, D. A., Miranda-Angulo, A., Yang, Y., Wang, H., Jiang, L., 
Yoshida, A. C., Kataoka, A., Mashiko, H., Avetisyan, M., et al. (2010). A genomic 
atlas of mouse hypothalamic development. Nat. Neurosci. 13, 767–775. 
Silva, B. A., Mattucci, C., Krzywkowski, P., Murana, E., Illarionova, A., Grinevich,  
V., Canteras, N. S., Ragozzino, D. and Gross, C. T. (2013). Independent hypothalamic  
circuits for social and predator fear. Nat. Neurosci. 16, 1731–1733. 
 
Spoelgen, R., Hammes, A., Anzenberger, U., Zechner, D., Andersen, O. M., 
Jerchow, B. and Willnow, T. E. (2005). LRP2/megalin is required for patterning of the 
ventral telencephalon. Development 132, 405–414. 
 
Stacher Hörndli C. and Chien C.-B. (2012). Sonic hedgehog is indirectly required for 
intraretinal axon pathfinding by regulating chemokine expression in the optic stalk. 
Development 139, 2604-2613. 
 
Strömland K. (1987). Ocular involvement in the fetal alcohol syndrome. Surv. 
Ophthalmol. 31, 277-284. 
 
Sulik K. K., Johnston M. C. and Webb M. A. (1981). Fetal alcohol syndrome: 
embryogenesis in a mouse model. Science 214, 936-938. 
 
Sussel, L., Marin, O., Kimura, S. and Rubenstein, J. L. (1999). Loss of Nkx2.1 
homeobox gene function results in a ventral to dorsal molecular respecification within the 
basal telencephalon: evidence for a transformation of the pallidum into the striatum. 
Development 126, 3359–3370.  
104 
 
Szabó, N.-E., Zhao, T., Çankaya, M., Theil, T., Zhou, X. and Alvarez-Bolado, G. 
(2009). Role of neuroepithelial Sonic hedgehog in hypothalamic patterning. J. Neurosci. 
29, 6989. 
 
Tan, C. L. and Knight, Z. A. (2018). Regulation of Body Temperature by the Nervous 
System. Neuron 98, 31–48. 
 
Tenzen T., Allen B. L., Cole F., Kang J.-S., Krauss R. S. and McMahon A. P. (2006).  
The cell surface membrane proteins Cdo and Boc are components and targets of the 
Hedgehog signaling pathway and feedback network in mice. Dev. Cell 10, 647-656. 
 
Tran, P. V., Lee, M. B., Marín, O., Xu, B., Jones, K. R., Reichardt, L. F., Rubenstein, 
J. R. and Ingraham, H. A. (2003). Requirement of the orphan nuclear receptor SF-1 in 
terminal differentiation of ventromedial hypothalamic neurons. Molecular and Cellular 
Neuroscience 22, 441–453. 
 
Treier M., O'Connell S., Gleiberman A., Price J., Szeto D. P., Burgess R., Chuang P. 
T., McMahon A. P. and Rosenfeld M. G. (2001). Hedgehog signaling is required for 
pituitary gland development. Development 128, 377-386. 
 
Trowe, M.-O., Zhao, L., Weiss, A.-C., Christoffels, V., Epstein, D. J. and Kispert, A. 
(2013). Inhibition of Sox2-dependent activation of Shh in the ventral diencephalon by 
Tbx3 is required for formation of the neurohypophysis. Development 140, 2299–2309. 
 
Van den Heuvel, M., and Ingham, P.W. (1996). smoothened encodes a receptor-like 
serpentine protein required for hedgehog signalling. Nature 382, 547–551. 
Veazey K. J., Parnell S. E., Miranda R. C. and Golding M. C. (2015). Dose-dependent 
alcohol-induced alterations in chromatin structure persist beyond the window of 
exposure and correlate with fetal alcohol syndrome birth defects. Epigenetics Chromatin 
8, 39. 
 
Vokes, S.A., Ji, H., McCuine, S., Tenzen, T., Giles, S., Zhong, S., Longabaugh, W.J., 
Davidson, E.H., Wong, W.H., McMahon, A.P. (2007). Genomic characterization of Gli-
activator targets in sonic hedgehog-mediated neural patterning. Development 134, 
1977–1989. 
 
Wallace, V. A. (1999). Purkinje-cell-derived Sonic hedgehog regulates granule neuron 
precursor cell proliferation in the developing mouse cerebellum. Curr. Biol. 9, 445–448. 
 
Wallace, R. H., Freeman, J. L., Shouri, M. R., Izzillo, P. A., Rosenfeld, J. V., Mulley, 
J. C., Harvey, A. S. and Berkovic, S. F. (2008). Somatic mutations in GLI3 can cause 
hypothalamic hamartoma and gelastic seizures. Neurology 70, 653–655. 
 
Wang S. W., Kim B. S., Ding K., Wang H., Sun D., Johnson R. L., Klein W. H. and 
Gan L. (2001). Requirement for math5 in the development of retinal ganglion cells. 
Genes Dev. 15, 24-29. 
105 
 
Wang Y., Dakubo G. D., Thurig S., Mazerolle C. J. and Wallace V. A. (2005). Retinal 
ganglion cell-derived sonic hedgehog locally controls proliferation and the timing of RGC 
development in the embryonic mouse retina. Development 132, 5103-5113. 
 
Wang Y., Martin J. F. and Bai C. B. (2010). Direct and indirect requirements of Shh/Gli 
signaling in early pituitary development. Dev. Biol. 348, 199-209. 
 
Webb E. A. and Dattani M. T. (2010). Septo-optic dysplasia. Eur. J. Hum. Genet. 18, 
393-397. 
 
Wechsler-Reya, R. J. and Scott, M. P. (1999). Control of neuronal precursor 
proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103–114. 
 
Wray, S., Grant, P. and Gainer, H. (1989). Evidence that cells expressing luteinizing 
hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the 
olfactory placode. Proc. Natl. Acad. Sci. U.S.A. 86, 8132–8136. 
 
Wray, S. (2002). Development of gonadotropin-releasing hormone-1 neurons. Front 
Neuroendocrinol 23, 292–316. 
 
Wu F., Kaczynski T. J., Sethuramanujam S., Li R., Jain V., Slaughter M. and Mu X. 
(2015). Two transcription factors, Pou4f2 and Isl1, are sufficient to specify the retinal 
ganglion cell fate. Proc. Natl. Acad. Sci. USA 112, E1559-E1568. 
 
Xie, Y. and Dorsky, R. I. (2017). Development of the hypothalamus: conservation, 
modification and innovation. Development 144, 1588–1599. 
 
Xu, Q., Guo, L., Moore, H., Waclaw, R. R., Campbell, K. and Anderson, S. A. (2010). 
Sonic Hedgehog Signaling Confers Ventral Telencephalic Progenitors with Distinct 
Cortical Interneuron Fates. Neuron 65, 328–340. 
 
Yee, C. L., Wang, Y., Anderson, S., Ekker, M. and Rubenstein, J. L. R. (2009). 
Arcuate nucleus expression of NKX2.1 and DLX and lineages expressing these 
transcription factors in neuropeptide Y(+), proopiomelanocortin(+), and tyrosine 
hydroxylase(+) neurons in neonatal and adult mice. J. Comp. Neurol. 517, 37–50. 
 
Yin, W. and Gore, A. C. (2010). The Hypothalamic Median Eminence and its Role in 
Reproductive Aging. Ann N Y Acad Sci 1204, 113–122. 
 
Yu, K., McGlynn, S. and Matise, M. P. (2013). Floor plate-derived sonic hedgehog 
regulates glial and ependymal cell fates in the developing spinal cord. Development 140, 
1594–1604 
 
Zha, X. and Xu, X. (2015). Dissecting the hypothalamic pathways that underlie innate 
behaviors. Neurosci. Bull. 31, 629–648. 
106 
 
Zhang, F., and Jetten, A.M. (2001). Genomic structure of the gene encoding GLI-related, 
Krüppel-like zinc finger protein GLIS2. Gene 280, 49–57 
Zhang X. M. and Yang X. J. (2001). Regulation of retinal ganglion cell production by 
Sonic hedgehog. Development 128, 943-957. 
 
Zhang W., Kang J.-S., Cole F., Yi M.-J. and Krauss R. S. (2006). Cdo functions at 
multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately 
model human holoprosencephaly. Dev. Cell 10, 657-665. 
 
Zhang W., Mulieri P. J., Gaio U., Bae G.-U., Krauss R. S. and Kang J.-S. (2009). 
Ocular abnormalities in mice lacking the immunoglobulin superfamily member Cdo. 
FEBS J. 276, 5998-6010. 
 
Zhang C., Turton Q. M., Mackinnon S., Sulik K. K. and Cole G. J. (2011). Agrin 
function associated with ocular development is a target of ethanol exposure in  
embryonic zebrafish. Birth Defects Res. A Clin. Mol. Teratol. 91, 129-141. 
 
Zhao, L., Kim, K. W., Ikeda, Y., Anderson, K. K., Beck, L., Chase, S., Tobet, S. A. 
and Parker, K. L. (2008). Central nervous system-specific knockout of steroidogenic 
factor 1 results in increased anxiety-like behavior. Mol. Endocrinol. 22, 1403–1415. 
 
Zhao, L., Zevallos, S. E., Rizzoti, K., Jeong, Y., Lovell-Badge, R. and Epstein, D. J. 
(2012). Disruption of SoxB1-dependent Sonic hedgehog expression in the hypothalamus 
causes Septo-optic Dysplasia. Developmental Cell 22, 585–596. 
 
Zhu, X., Gleiberman, A. S. and Rosenfeld, M. G. (2007). Molecular Physiology of 
Pituitary Development: Signaling and Transcriptional Networks. Physiological Reviews 
87, 933–963. 
 
 
 
